| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 ATR BCKDK MELK PIK3R4 KSR1 TAOK3 CLK2 DSTYK TAOK1 TP53RK TBK1 TNK2 MAPK7 RSKR | 7.42e-06 | 363 | 210 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 1.13e-05 | 5 | 210 | 3 | GO:0004749 | |
| GeneOntologyMolecularFunction | kinase activity | PRPS2 SMG1 ATR BCKDK MELK PRPS1L1 PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK PIPSL DGKD TBK1 DGKI TNK2 MAPK7 RSKR PRPS1 | 1.94e-05 | 764 | 210 | 22 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 ATR BCKDK MELK PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK TBK1 TNK2 MAPK7 RSKR | 2.13e-05 | 446 | 210 | 16 | GO:0004674 |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 2.24e-05 | 6 | 210 | 3 | GO:0016778 | |
| GeneOntologyMolecularFunction | helicase activity | 4.60e-05 | 158 | 210 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 4.74e-05 | 62 | 210 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.02e-05 | 127 | 210 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1F MYO5C DHX8 DDX10 DDX11 BPTF NAV3 HFM1 ASCC3 DDX11L8 DYNC1H1 DHX16 DNHD1 RAD50 MSH6 MCM9 MYH15 DNAH11 | 9.14e-05 | 614 | 210 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.26e-04 | 25 | 210 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | mismatch repair complex binding | 1.78e-04 | 11 | 210 | 3 | GO:0032404 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 ATR BCKDK MELK PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK PIPSL DGKD TBK1 DGKI TNK2 MAPK7 RSKR | 1.87e-04 | 709 | 210 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PRPS2 SMG1 ATR BCKDK MELK PRPS1L1 PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK PIPSL DGKD TBK1 DGKI TNK2 MAPK7 RSKR PRPS1 | 3.77e-04 | 938 | 210 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 3.83e-04 | 14 | 210 | 3 | GO:0051880 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DCDC1 SPTA1 SPTB SPTBN1 SPTBN2 EML6 ACTN1 TUBGCP2 ACE MYO5C PTPN4 ABRAXAS1 SYNE2 NAV3 TAOK1 SYNE1 TRAK1 BICDL1 SLC8A1 PLEKHG3 TTLL11 TLN1 MYH15 MYBPC3 | 5.69e-04 | 1099 | 210 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 ATR BCKDK MELK PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK TBK1 TNK2 MAPK7 RSKR | 6.37e-04 | 600 | 210 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | triplex DNA binding | 6.51e-04 | 4 | 210 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.93e-04 | 227 | 210 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.33e-04 | 18 | 210 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | GBF1 SBF1 GPSM2 SGSM3 DOCK6 PREX1 WNT11 RGS16 ARHGEF10L PREB PLEKHG3 DGKI TNK2 RAPGEF2 | 9.93e-04 | 507 | 210 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | GBF1 SBF1 GPSM2 SGSM3 DOCK6 PREX1 WNT11 RGS16 ARHGEF10L PREB PLEKHG3 DGKI TNK2 RAPGEF2 | 9.93e-04 | 507 | 210 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | TRAIL binding | 1.08e-03 | 5 | 210 | 2 | GO:0045569 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.08e-03 | 5 | 210 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DHX8 DDX10 DDX11 RHOBTB2 NAV3 HFM1 GNAT1 GNAT2 ASCC3 DDX11L8 DYNC1H1 DHX16 DRG2 RGS16 RAD50 MCM9 GNAT3 DNAH11 | 1.44e-03 | 775 | 210 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.56e-03 | 80 | 210 | 5 | GO:0008186 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.74e-03 | 23 | 210 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | actin binding | SPTA1 SPTB SPTBN1 SPTBN2 ACTN1 ACE MYO5C SYNE2 SYNE1 PLEKHG3 TLN1 MYH15 MYBPC3 | 1.74e-03 | 479 | 210 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 2.22e-03 | 25 | 210 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | MutSalpha complex binding | 2.23e-03 | 7 | 210 | 2 | GO:0032407 | |
| GeneOntologyMolecularFunction | MutLalpha complex binding | 2.23e-03 | 7 | 210 | 2 | GO:0032405 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX8 DDX10 DDX11 NAV3 HFM1 ASCC3 DDX11L8 DYNC1H1 DHX16 RAD50 MCM9 DNAH11 | 2.55e-03 | 441 | 210 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.55e-03 | 130 | 210 | 6 | GO:0005200 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | PABIR1 ATR FANCD2 TAOK3 ABRAXAS1 MAD1L1 TAOK1 RPA4 KNL1 HUS1 ZFY RAD50 FBXO31 | 3.51e-07 | 217 | 209 | 13 | GO:0000075 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | PABIR1 ATR FANCD2 TAOK3 ABRAXAS1 MAD1L1 TAOK1 KNL1 HUS1 RAD50 FBXO31 | 8.88e-07 | 163 | 209 | 11 | GO:0007093 |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 2.17e-06 | 59 | 209 | 7 | GO:0044818 | |
| GeneOntologyBiologicalProcess | DNA repair | SMG1 ATR ACTR5 POGZ DDB1 DDX11 FANCD2 KAT2B TAOK3 UBR5 ABRAXAS1 TAOK1 ASCC3 NONO RPA4 DDX11L8 HUS1 RAD50 MSH6 MCM9 PSMD14 | 2.92e-06 | 648 | 209 | 21 | GO:0006281 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SMG1 ATR TNFSF10 ACTR5 SPTA1 SPTB SPTBN1 SPTBN2 DDX11 KAT2B HECW2 SYNE2 MAD1L1 SEC16A NAV3 GPSM2 TAOK1 SGSM3 ARMH3 PREX1 DYNC1H1 KNL1 TCHP SYNE1 WNT11 SPECC1L ARHGEF10L ZFY RAD50 VANGL2 PREB TMED9 | 5.41e-06 | 1342 | 209 | 32 | GO:0033043 |
| GeneOntologyBiologicalProcess | negative regulation of G2/M transition of mitotic cell cycle | 1.10e-05 | 75 | 209 | 7 | GO:0010972 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.17e-05 | 105 | 209 | 8 | GO:1901879 | |
| GeneOntologyBiologicalProcess | organelle assembly | CLUAP1 GBF1 ZNF423 SPEF2 SPTBN2 POGZ TUBGCP2 CSMD2 DDB1 CFAP100 KAT2B NRXN3 ABRAXAS1 SYNE2 GPSM2 SGSM3 DYNC1H1 NOTCH1 KNL1 DNHD1 RPGRIP1 TCHP SYNE1 VANGL2 NCOR1 CEP250 SPAG17 MYBPC3 | 1.27e-05 | 1138 | 209 | 28 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G2/M phase transition | 1.31e-05 | 77 | 209 | 7 | GO:1902750 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | PABIR1 DCDC1 ATR DDB1 DDX11 FANCD2 PIK3R4 KAT2B TAOK3 ABRAXAS1 HECW2 MAD1L1 GPSM2 TAOK1 RPA4 DYNC1H1 KNL1 HUS1 ZFY RAD50 FBXO31 CEP250 RAB11FIP4 | 1.69e-05 | 845 | 209 | 23 | GO:0010564 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | PABIR1 ATR FANCD2 TAOK3 ABRAXAS1 MAD1L1 TAOK1 RPA4 KNL1 HUS1 ZFY RAD50 FBXO31 | 1.84e-05 | 311 | 209 | 13 | GO:1901988 |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 2.01e-05 | 6 | 209 | 3 | GO:0046391 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 2.01e-05 | 6 | 209 | 3 | GO:0006015 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | PABIR1 ATR FANCD2 KAT2B TAOK3 ABRAXAS1 MAD1L1 TAOK1 RPA4 KNL1 HUS1 ZFY RAD50 FBXO31 | 2.09e-05 | 362 | 209 | 14 | GO:0010948 |
| GeneOntologyBiologicalProcess | cell cycle process | PABIR1 DCDC1 ATR SPTBN1 POGZ TUBGCP2 MELK DDB1 DDX11 FANCD2 PIK3R4 KAT2B TAOK3 ABRAXAS1 HECW2 MAD1L1 GPSM2 TAOK1 HFM1 RPA4 DDX11L8 DYNC1H1 KNL1 HUS1 ZFY RAD50 NCOR1 MSH6 FBXO31 CEP250 CTDP1 RAB11FIP4 | 2.27e-05 | 1441 | 209 | 32 | GO:0022402 |
| GeneOntologyBiologicalProcess | chromosome organization | SMG1 ATR ACTR5 POGZ DDX11 FANCD2 KAT2B ABRAXAS1 HECW2 MAD1L1 HFM1 ASCC3 DDX11L8 KNL1 NUP107 HUS1 NUP98 RAD50 MSH6 MCM9 | 2.36e-05 | 686 | 209 | 20 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 3.38e-05 | 89 | 209 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | cilium assembly | CLUAP1 GBF1 ZNF423 SPEF2 CFAP100 SYNE2 SGSM3 NOTCH1 DNHD1 RPGRIP1 TCHP SYNE1 VANGL2 CEP250 SPAG17 | 5.04e-05 | 444 | 209 | 15 | GO:0060271 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 7.16e-05 | 100 | 209 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | PABIR1 GBF1 DCDC1 ATR ACTR5 MECOM DDB1 DDX11 FANCD2 PIK3R4 KAT2B TAOK3 ABRAXAS1 HECW2 MAD1L1 GPSM2 TAOK1 SGSM3 RPA4 DYNC1H1 KNL1 SRA1 HUS1 ZFY RAD50 FBXO31 CEP250 RAB11FIP4 | 7.29e-05 | 1256 | 209 | 28 | GO:0051726 |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 7.55e-05 | 136 | 209 | 8 | GO:0000077 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | PABIR1 ATR TAOK3 ABRAXAS1 MAD1L1 TAOK1 KNL1 HUS1 RAD50 FBXO31 | 8.33e-05 | 219 | 209 | 10 | GO:1901991 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | PABIR1 GBF1 DCDC1 ATR SPTBN1 TUBGCP2 MELK DDB1 FANCD2 KAT2B TAOK3 ABRAXAS1 HECW2 MAD1L1 GPSM2 TAOK1 DYNC1H1 KNL1 SRA1 HUS1 RAD50 FBXO31 CEP250 CTDP1 | 1.01e-04 | 1014 | 209 | 24 | GO:0000278 |
| GeneOntologyBiologicalProcess | background adaptation | 1.02e-04 | 2 | 209 | 2 | GO:0120302 | |
| GeneOntologyBiologicalProcess | cilium organization | CLUAP1 GBF1 ZNF423 SPEF2 CFAP100 SYNE2 SGSM3 NOTCH1 DNHD1 RPGRIP1 TCHP SYNE1 VANGL2 CEP250 SPAG17 | 1.10e-04 | 476 | 209 | 15 | GO:0044782 |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 CLUAP1 GBF1 NUP62CL MYO5C LAPTM5 PIK3R4 UBR5 SYNE2 SEC16A PEX5 DYNC1H1 NOTCH1 CCHCR1 NUP107 SYNE1 NUP98 CPT1A TRAK1 PREB BICDL1 USO1 GCC2 ASPH TMED9 SERAC1 NUP188 RAB11FIP4 RASSF9 SPAG17 MYBPC3 | 1.12e-04 | 1496 | 209 | 31 | GO:0046907 |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.13e-04 | 144 | 209 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.13e-04 | 144 | 209 | 8 | GO:0043244 | |
| GeneOntologyBiologicalProcess | DNA damage response | SMG1 ATR ACTR5 POGZ DDB1 DDX11 FANCD2 KAT2B TAOK3 UBR5 ABRAXAS1 TAOK1 ASCC3 NONO RPA4 DDX11L8 HUS1 RAD50 MSH6 YJU2 FBXO31 MCM9 PSMD14 | 1.17e-04 | 959 | 209 | 23 | GO:0006974 |
| GeneOntologyBiologicalProcess | DNA integrity checkpoint signaling | 1.18e-04 | 145 | 209 | 8 | GO:0031570 | |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 1.41e-04 | 78 | 209 | 6 | GO:0032508 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | GBF1 MYO5C KAT2B ABRAXAS1 SYNE2 MAD1L1 SEC16A GPSM2 DYNC1H1 KNL1 SYNE1 PCLO TRAK1 PREB BICDL1 TMED9 | 1.49e-04 | 546 | 209 | 16 | GO:0051656 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | PABIR1 ATR FANCD2 TAOK3 ABRAXAS1 MAD1L1 TAOK1 KNL1 HUS1 RAD50 FBXO31 | 1.50e-04 | 282 | 209 | 11 | GO:0045930 |
| GeneOntologyBiologicalProcess | meiotic cell cycle checkpoint signaling | 1.59e-04 | 11 | 209 | 3 | GO:0033313 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 1.64e-04 | 152 | 209 | 8 | GO:0000086 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.80e-04 | 52 | 209 | 5 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 1.82e-04 | 116 | 209 | 7 | GO:0010389 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | SPTA1 SPTB SPTBN1 SPTBN2 DHX8 PIK3R4 NAV3 PEX5 TAOK1 SPECC1L ASPH | 1.97e-04 | 291 | 209 | 11 | GO:0032984 |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 2.10e-04 | 200 | 209 | 9 | GO:0042770 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | PABIR1 ATR MELK DDB1 FANCD2 TAOK3 ABRAXAS1 HECW2 MAD1L1 TAOK1 RPA4 KNL1 HUS1 ZFY RAD50 FBXO31 CTDP1 | 2.33e-04 | 627 | 209 | 17 | GO:0044770 |
| GeneOntologyBiologicalProcess | DNA geometric change | 2.41e-04 | 86 | 209 | 6 | GO:0032392 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | PABIR1 ATR DDB1 FANCD2 TAOK3 ABRAXAS1 HECW2 MAD1L1 TAOK1 RPA4 KNL1 HUS1 ZFY RAD50 FBXO31 | 2.62e-04 | 516 | 209 | 15 | GO:1901987 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | PABIR1 ATR FANCD2 KAT2B TAOK3 ABRAXAS1 MAD1L1 TAOK1 RPA4 KNL1 HUS1 ZFY RAD50 FBXO31 | 2.89e-04 | 464 | 209 | 14 | GO:0045786 |
| GeneOntologyBiologicalProcess | post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery | 3.05e-04 | 3 | 209 | 2 | GO:0000973 | |
| GeneOntologyBiologicalProcess | neural tissue regeneration | 3.05e-04 | 3 | 209 | 2 | GO:0097719 | |
| GeneOntologyBiologicalProcess | organelle localization | GBF1 MYO5C KAT2B ABRAXAS1 SYNE2 MAD1L1 SEC16A GPSM2 DYNC1H1 KNL1 SYNE1 PCLO NUP98 TRAK1 PREB BICDL1 USO1 TMED9 | 3.06e-04 | 703 | 209 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | mitotic DNA damage checkpoint signaling | 3.28e-04 | 91 | 209 | 6 | GO:0044773 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 3.64e-04 | 171 | 209 | 8 | GO:0044839 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 3.82e-04 | 61 | 209 | 5 | GO:0030834 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | SPTA1 SPTB SPTBN1 SPTBN2 KAT2B MAD1L1 NAV3 TAOK1 KNL1 TCHP SPECC1L ZFY RAD50 | 3.82e-04 | 421 | 209 | 13 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 3.83e-04 | 131 | 209 | 7 | GO:1902749 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 3.91e-04 | 94 | 209 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CLUAP1 SPEF2 TUBGCP2 DDB1 CFAP100 KAT2B ABRAXAS1 SYNE2 NAV3 GPSM2 TAOK1 DYNC1H1 SPECC1L NCOR1 GCC2 TTLL11 CEP250 SPAG17 | 4.07e-04 | 720 | 209 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | mitotic DNA integrity checkpoint signaling | 4.14e-04 | 95 | 209 | 6 | GO:0044774 | |
| GeneOntologyBiologicalProcess | vesicle targeting, to, from or within Golgi | 4.19e-04 | 35 | 209 | 4 | GO:0048199 | |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 4.27e-04 | 15 | 209 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | head development | ZNF148 ZNF423 SPEF2 SPTBN2 MECOM TUBGCP2 DDX10 S100A1 FANCD2 BPTF SYNE2 SEC16A PEX5 NOTCH1 SCHIP1 SPECC1L SLC1A2 NCOR1 ZNF335 ASPH RAPGEF2 | 4.45e-04 | 919 | 209 | 21 | GO:0060322 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | PABIR1 DCDC1 ATR SPTBN1 MELK DDB1 FANCD2 KAT2B TAOK3 ABRAXAS1 HECW2 MAD1L1 GPSM2 TAOK1 DYNC1H1 KNL1 HUS1 RAD50 FBXO31 CTDP1 | 4.49e-04 | 854 | 209 | 20 | GO:1903047 |
| GeneOntologyBiologicalProcess | double-strand break repair | ATR ACTR5 POGZ DDX11 FANCD2 ABRAXAS1 RPA4 HUS1 RAD50 MCM9 PSMD14 | 4.91e-04 | 324 | 209 | 11 | GO:0006302 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 5.51e-04 | 66 | 209 | 5 | GO:0030042 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | GBF1 ATR SPTA1 SPTB SPTBN1 SPTBN2 DHX8 PIK3R4 NAV3 PEX5 TAOK1 ASCC3 SPECC1L VANGL2 PLXNC1 ASPH | 5.78e-04 | 617 | 209 | 16 | GO:0022411 |
| GeneOntologyBiologicalProcess | RNA splicing | SART3 RBM48 DHX8 KAT2B CLK2 TDRD6 NONO DHX16 NUP98 GRSF1 SNRNP48 YJU2 SF3B1 PRPF38A | 6.32e-04 | 502 | 209 | 14 | GO:0008380 |
| GeneOntologyBiologicalProcess | roof of mouth development | 6.70e-04 | 104 | 209 | 6 | GO:0060021 | |
| GeneOntologyBiologicalProcess | vesicle coating | 7.03e-04 | 40 | 209 | 4 | GO:0006901 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | PABIR1 ATR MELK DDB1 TAOK3 ABRAXAS1 HECW2 MAD1L1 TAOK1 KNL1 HUS1 RAD50 FBXO31 CTDP1 | 7.23e-04 | 509 | 209 | 14 | GO:0044772 |
| GeneOntologyBiologicalProcess | vesicle targeting | 7.71e-04 | 71 | 209 | 5 | GO:0006903 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 8.37e-04 | 194 | 209 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | PABIR1 ATR DDB1 TAOK3 ABRAXAS1 HECW2 MAD1L1 TAOK1 KNL1 HUS1 RAD50 FBXO31 | 8.58e-04 | 402 | 209 | 12 | GO:1901990 |
| GeneOntologyBiologicalProcess | vesicle localization | 9.70e-04 | 247 | 209 | 9 | GO:0051648 | |
| GeneOntologyBiologicalProcess | regulation of COPII vesicle coating | 1.00e-03 | 5 | 209 | 2 | GO:0003400 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.18e-06 | 9 | 209 | 4 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 1.18e-06 | 9 | 209 | 4 | GO:0008091 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SART3 ATR ACTR5 NUP62CL MECOM RBM48 DHX8 DDX11 BPTF ABRAXAS1 SYNE2 MAD1L1 SAGE1 ASCC3 NONO RPA4 DDX11L8 DHX16 NUP107 HUS1 PHF12 SYNE1 NUP98 RAD50 NCOR1 MSH6 SNRNP48 YJU2 SF3B1 ZNF335 PRPF38A NUP188 | 6.98e-06 | 1377 | 209 | 32 | GO:0140513 |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 9.71e-06 | 5 | 209 | 3 | GO:0002189 | |
| GeneOntologyCellularComponent | spindle | DCDC1 TUBGCP2 DDX11 CEP170 KAT2B HECW2 MAD1L1 GPSM2 DDX11L8 RASSF10 SPECC1L NCOR1 FRY CEP250 CTDP1 RAB11FIP4 | 2.25e-05 | 471 | 209 | 16 | GO:0005819 |
| GeneOntologyCellularComponent | microtubule organizing center | CLUAP1 TUBGCP2 DDX11 CFAP100 CEP170 KAT2B MAD1L1 GPSM2 DDX11L8 DYNC1H1 CCHCR1 FAM184A TCHP RASSF10 SPECC1L BICDL1 FRY USO1 FBXO31 TTLL11 CEP250 CTDP1 RAB11FIP4 | 5.06e-05 | 919 | 209 | 23 | GO:0005815 |
| GeneOntologyCellularComponent | cytoplasmic region | PIK3R4 CFAP100 GPSM2 DYNC1H1 DNHD1 RPGRIP1 TCHP PCLO TRAK1 GNAT3 ABHD13 SPAG17 DNAH11 | 7.26e-05 | 360 | 209 | 13 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | SPTA1 SPTB SPTBN1 SPTBN2 ACTN1 MELK GPSM2 DYNC1H1 TCHP PCLO TRAK1 FRY ASPH | 9.81e-05 | 371 | 209 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | spindle pole | 2.29e-04 | 205 | 209 | 9 | GO:0000922 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SPTBN2 LAPTM5 BPTF FAT1 SBF1 UBR5 SEC16A TAOK1 DOCK6 PREX1 TRMT112 SYNE1 PCLO TRAK1 RAD50 NCOR1 USO1 CEP250 DGKI TNK2 RAPGEF2 | 4.62e-04 | 934 | 209 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | centrosome | CLUAP1 TUBGCP2 DDX11 CEP170 KAT2B MAD1L1 GPSM2 DDX11L8 DYNC1H1 FAM184A TCHP RASSF10 BICDL1 FRY FBXO31 CEP250 CTDP1 RAB11FIP4 | 7.61e-04 | 770 | 209 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.11e-03 | 78 | 209 | 5 | GO:0001917 | |
| MousePheno | abnormal ventricle myocardium morphology | 1.49e-05 | 116 | 175 | 9 | MP:0010499 | |
| MousePheno | abnormal prenatal body size | SART3 SMG1 ZNF148 ACTR5 SPTBN1 MECOM POGZ RBM48 ACE DDX10 DDX11 BPTF GRK2 UBR5 DDX11L8 NOTCH1 STRN3 HUS1 NUP98 DGKD ZFY RAD50 VANGL2 NCOR1 SLC8A1 TLN1 CTDP1 WDFY3 RAPGEF2 MAPK7 | 5.16e-05 | 1116 | 175 | 30 | MP:0010866 |
| MousePheno | abnormal embryo size | SART3 SMG1 ZNF148 ACTR5 SPTBN1 MECOM RBM48 ACE DDX10 DDX11 BPTF GRK2 UBR5 DDX11L8 NOTCH1 STRN3 HUS1 NUP98 ZFY RAD50 VANGL2 NCOR1 SLC8A1 TLN1 CTDP1 RAPGEF2 MAPK7 | 5.62e-05 | 956 | 175 | 27 | MP:0001697 |
| MousePheno | decreased embryo size | SMG1 SPTBN1 MECOM DDX11 BPTF GRK2 UBR5 DDX11L8 NOTCH1 STRN3 HUS1 NUP98 ZFY RAD50 VANGL2 NCOR1 SLC8A1 TLN1 CTDP1 RAPGEF2 MAPK7 | 7.74e-05 | 659 | 175 | 21 | MP:0001698 |
| MousePheno | myocardial trabeculae hypoplasia | 8.34e-05 | 58 | 175 | 6 | MP:0010503 | |
| Domain | SPEC | 1.32e-09 | 32 | 201 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.32e-09 | 32 | 201 | 8 | IPR018159 | |
| Domain | Spectrin | 3.19e-09 | 23 | 201 | 7 | PF00435 | |
| Domain | Spectrin_repeat | 1.92e-08 | 29 | 201 | 7 | IPR002017 | |
| Domain | CH | 8.67e-08 | 73 | 201 | 9 | PS50021 | |
| Domain | CH-domain | 1.10e-07 | 75 | 201 | 9 | IPR001715 | |
| Domain | ACTININ_2 | 1.25e-07 | 23 | 201 | 6 | PS00020 | |
| Domain | ACTININ_1 | 1.25e-07 | 23 | 201 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.25e-07 | 23 | 201 | 6 | IPR001589 | |
| Domain | CH | 4.67e-07 | 65 | 201 | 8 | SM00033 | |
| Domain | CH | 8.35e-07 | 70 | 201 | 8 | PF00307 | |
| Domain | - | 9.32e-07 | 71 | 201 | 8 | 1.10.418.10 | |
| Domain | PRPP_SYNTHASE | 1.23e-06 | 3 | 201 | 3 | PS00114 | |
| Domain | PRib_PP_synth_CS | 1.23e-06 | 3 | 201 | 3 | IPR000842 | |
| Domain | Spectrin_bsu | 4.87e-06 | 4 | 201 | 3 | IPR016343 | |
| Domain | Pribosyltran_N | 1.21e-05 | 5 | 201 | 3 | PF13793 | |
| Domain | Pribosyl_synth | 1.21e-05 | 5 | 201 | 3 | PF14572 | |
| Domain | Rib-P_diPkinase | 1.21e-05 | 5 | 201 | 3 | IPR005946 | |
| Domain | Pribosyltran_N | 1.21e-05 | 5 | 201 | 3 | IPR029099 | |
| Domain | P-loop_NTPase | SPEF2 MYO5C DHX8 DDX10 DDX11 RHOBTB2 NAV3 HFM1 GNAT1 GNAT2 ASCC3 DYNC1H1 CARD14 DHX16 DNHD1 DRG2 IFI44 RAD50 MSH6 MCM9 GNAT3 MYH15 DNAH11 | 4.43e-05 | 848 | 201 | 23 | IPR027417 |
| Domain | - | SPEF2 DHX8 DDX10 DDX11 RHOBTB2 NAV3 HFM1 GNAT1 GNAT2 ASCC3 DYNC1H1 CARD14 DHX16 DNHD1 DRG2 IFI44 RAD50 MSH6 MCM9 GNAT3 DNAH11 | 5.73e-05 | 746 | 201 | 21 | 3.40.50.300 |
| Domain | Gprotein_alpha_I | 6.61e-05 | 8 | 201 | 3 | IPR001408 | |
| Domain | Pribosyltran | 1.90e-04 | 11 | 201 | 3 | PF00156 | |
| Domain | PRTase-like | 2.51e-04 | 12 | 201 | 3 | IPR029057 | |
| Domain | PRibTrfase_dom | 2.51e-04 | 12 | 201 | 3 | IPR000836 | |
| Domain | - | 2.51e-04 | 12 | 201 | 3 | 3.40.50.2020 | |
| Domain | Dynein_HC_stalk | 4.10e-04 | 14 | 201 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.10e-04 | 14 | 201 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.10e-04 | 14 | 201 | 3 | PF08393 | |
| Domain | MT | 4.10e-04 | 14 | 201 | 3 | PF12777 | |
| Domain | DHC_fam | 5.08e-04 | 15 | 201 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.08e-04 | 15 | 201 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.08e-04 | 15 | 201 | 3 | IPR004273 | |
| Domain | GproteinA_insert | 6.20e-04 | 16 | 201 | 3 | IPR011025 | |
| Domain | - | 6.20e-04 | 16 | 201 | 3 | 1.10.400.10 | |
| Domain | G-alpha | 6.20e-04 | 16 | 201 | 3 | PF00503 | |
| Domain | G_alpha | 6.20e-04 | 16 | 201 | 3 | SM00275 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | IPR012315 | |
| Domain | Sec63 | 6.82e-04 | 4 | 201 | 2 | PF02889 | |
| Domain | Sec63 | 6.82e-04 | 4 | 201 | 2 | SM00973 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | PS51049 | |
| Domain | Sec63-dom | 6.82e-04 | 4 | 201 | 2 | IPR004179 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | SM01249 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | PF10541 | |
| Domain | N-RASSF | 6.82e-04 | 4 | 201 | 2 | IPR033593 | |
| Domain | Gprotein_alpha_su | 7.47e-04 | 17 | 201 | 3 | IPR001019 | |
| Domain | FATC | 1.13e-03 | 5 | 201 | 2 | PF02260 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.14e-03 | 73 | 201 | 5 | IPR011545 | |
| Domain | DEAD | 1.14e-03 | 73 | 201 | 5 | PF00270 | |
| Domain | EFhand_Ca_insen | 1.68e-03 | 6 | 201 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.68e-03 | 6 | 201 | 2 | IPR014837 | |
| Domain | FAT | 1.68e-03 | 6 | 201 | 2 | PS51189 | |
| Domain | FATC | 1.68e-03 | 6 | 201 | 2 | PS51190 | |
| Domain | FATC_dom | 1.68e-03 | 6 | 201 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.68e-03 | 6 | 201 | 2 | IPR014009 | |
| Domain | FATC | 1.68e-03 | 6 | 201 | 2 | SM01343 | |
| Domain | S_TKc | MELK PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK TBK1 MAPK7 | 1.82e-03 | 359 | 201 | 11 | SM00220 |
| Domain | Kinase-like_dom | SMG1 ATR MELK PIK3R4 KSR1 TAOK3 GRK2 CLK2 DSTYK TAOK1 TP53RK TBK1 TNK2 MAPK7 | 2.27e-03 | 542 | 201 | 14 | IPR011009 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.73e-06 | 10 | 154 | 4 | MM15112 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | GBF1 SPTA1 SPTB SPTBN1 SPTBN2 SEC16A DYNC1H1 PREB USO1 TMED9 | 8.09e-06 | 156 | 154 | 10 | M27097 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | GBF1 SPTA1 SPTB SPTBN1 SPTBN2 SEC16A DYNC1H1 PREB USO1 TMED9 | 1.55e-05 | 168 | 154 | 10 | MM14785 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.56e-05 | 102 | 154 | 8 | M27648 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.70e-05 | 110 | 154 | 8 | MM15350 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | GBF1 SPTA1 SPTB SPTBN1 SPTBN2 SEC16A DYNC1H1 PREB USO1 TMED9 | 3.91e-05 | 187 | 154 | 10 | M961 |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 4.67e-05 | 19 | 154 | 4 | MM1478 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | GBF1 SPTA1 SPTB SPTBN1 SPTBN2 SEC16A DYNC1H1 PREB USO1 TMED9 | 7.49e-05 | 202 | 154 | 10 | MM15650 |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 8.60e-05 | 22 | 154 | 4 | M9703 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 2.55e-04 | 81 | 154 | 6 | M39490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_SIGNALING | 2.62e-04 | 12 | 154 | 3 | M47841 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.43e-04 | 31 | 154 | 4 | M877 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | ATR ABRAXAS1 MAD1L1 TAOK1 DYNC1H1 KNL1 NUP107 HUS1 NUP98 RAD50 PSMD14 | 3.54e-04 | 291 | 154 | 11 | M16647 |
| Pubmed | ZNF148 DCDC1 ACTR5 MCC MECOM POGZ TUBGCP2 DDB1 FANCD2 CEP170 BPTF KSR1 KAT2B FAT1 UBR5 SEC16A PEX5 HSD11B1 ASCC3 KNL1 NUP107 PHF12 ZNF629 ADNP2 RAD50 VANGL2 MSH6 ZNF526 TBK1 ZFHX3 NUP188 WDFY3 USP54 RAPGEF2 | 9.45e-15 | 1116 | 211 | 34 | 31753913 | |
| Pubmed | TRAF3 SPTBN1 SPTBN2 MCC DDB1 CEP170 SBF1 UBR5 SYNE2 MAD1L1 SEC16A PEX5 GOLGA3 DYNC1H1 SESTD1 STRN3 DRG2 SYNE1 HECTD4 SPECC1L SLC1A2 RAD50 NCOR1 FRY SF3B1 TBK1 DGKI TMED9 WDFY3 RAPGEF2 | 2.36e-13 | 963 | 211 | 30 | 28671696 | |
| Pubmed | SART3 SPTBN1 SPTBN2 POGZ ACTN1 DDB1 DHX8 DDX10 CEP170 BPTF SBF1 UBR5 SYNE2 SEC16A ASCC3 DYNC1H1 DHX16 NUP107 NUP98 RAD50 MSH6 SF3B1 TLN1 NUP188 HDLBP | 3.16e-13 | 653 | 211 | 25 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SPTBN2 ACTN1 DDB1 MYO5C DHX8 DDX10 CEP170 BPTF UBR5 SYNE2 SEC16A PEX5 ASCC3 NONO DYNC1H1 DHX16 NUP107 SYNE1 NUP98 SPECC1L RAD50 SF3B1 PLEKHG3 TBK1 TLN1 TMED9 NUP188 HDLBP | 3.37e-11 | 1024 | 211 | 28 | 24711643 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR SPTBN1 TUBGCP2 MELK DDB1 DHX8 STAB1 FANCD2 PIK3R4 MAD1L1 TAOK1 NONO DYNC1H1 KNL1 NUP107 RAD50 MSH6 SF3B1 USO1 TLN1 HDLBP | 8.21e-11 | 582 | 211 | 21 | 20467437 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | BCKDK SPTBN2 TUBGCP2 ACE DDB1 GRK2 UBR5 PEX5 DYNC1H1 USP53 CCHCR1 STRN3 FAM184A DRG2 HUS1 TRMT112 PHF12 RAD50 NCOR1 CEP250 TBK1 TLN1 IFFO2 USP54 PSMD14 | 9.86e-11 | 853 | 211 | 25 | 28718761 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 GBF1 ATR SPTBN1 POGZ DDB1 DHX8 DDX10 FANCD2 PIK3R4 TDRD6 ITM2B NONO DYNC1H1 DHX16 DNHD1 NUP107 SYNE1 PCLO NUP98 GRSF1 RAD50 MSH6 SF3B1 USO1 TBK1 TLN1 TMED9 NUP188 PSMD14 HDLBP PRPS1 | 1.81e-10 | 1425 | 211 | 32 | 30948266 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 ZNF148 ATR SPTBN1 POGZ FANCD2 BPTF MAD1L1 SEC16A TAOK1 DHX16 STRN3 PHF12 NUP98 RAD50 NCOR1 MSH6 SF3B1 ZNF335 ASPH CTDP1 PRPF38A HDLBP | 4.47e-10 | 774 | 211 | 23 | 15302935 |
| Pubmed | ZNF148 MECOM POGZ UBR5 SEC16A ASCC3 GOLGA3 KNL1 DRG2 NUP107 PHF12 RAD50 NCOR1 USO1 GCC2 TBK1 ZFHX3 | 9.29e-10 | 418 | 211 | 17 | 34709266 | |
| Pubmed | 1.32e-09 | 4 | 211 | 4 | 21412925 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.59e-09 | 85 | 211 | 9 | 16051665 | |
| Pubmed | GBF1 ITGA1 TUBGCP2 MELK PIK3R4 KSR1 GRK2 UBR5 HSD11B1 ASCC3 ITM2B NONO GOLGA3 DYNC1H1 DRG2 NUP107 CPT1A RAD50 PREB NBAS NCOR1 USO1 PLXNC1 GCC2 TNK2 ABHD13 NUP188 | 2.99e-09 | 1168 | 211 | 27 | 19946888 | |
| Pubmed | SART3 SPTA1 SPTB SPTBN1 SPTBN2 ACTN1 DDB1 PIK3R4 CEP170 GRK2 SBF1 HECW2 SEC16A GOLGA3 DYNC1H1 STRN3 SYNE1 PCLO RBP3 SPECC1L SLC1A2 SF3B1 USO1 TLN1 TMED9 USP54 RAPGEF2 DNAH11 HDLBP PRPS1 | 3.50e-09 | 1431 | 211 | 30 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 SPTBN1 POGZ ACTN1 MELK DDB1 DDX10 PIK3R4 SBF1 UBR5 SEC16A TP53RK ASCC3 NONO DYNC1H1 DHX16 NUP107 ADNP2 DGKD GRSF1 RAD50 MSH6 SF3B1 PLEKHG3 TLN1 ASPH PRPF38A WDFY3 HDLBP | 4.03e-09 | 1353 | 211 | 29 | 29467282 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 ZNF236 FAT1 SBF1 MAD1L1 SEC16A DOCK6 PREX1 DYNC1H1 NOTCH1 FRAS1 NRF1 PHF12 HECTD4 GRID1 RGS16 ARHGEF10L TRAK1 NCOR1 ZNF335 TLN1 CTDP1 DIP2C TNK2 NUP188 WDFY3 | 4.19e-09 | 1105 | 211 | 26 | 35748872 |
| Pubmed | SPTBN1 SPTBN2 POGZ ACTN1 NAV3 USP53 SYNE1 NUP98 ADNP2 SPECC1L SLC1A2 SF3B1 CEP250 TNK2 RAPGEF2 MAPK7 HDLBP | 8.80e-09 | 486 | 211 | 17 | 20936779 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 NUP62CL MCC POGZ TUBGCP2 DDB1 CEP170 UBR5 MAD1L1 GNAT1 GNAT2 NONO DYNC1H1 KNL1 DHX16 STRN3 NUP107 SYNE1 NUP98 PREB NBAS SF3B1 TLN1 IFFO2 GNAT3 NUP188 | 1.03e-08 | 1155 | 211 | 26 | 20360068 |
| Pubmed | SMG1 TRAF3 ZNF148 ACTR5 SPTBN1 MECOM POGZ DDB1 MYO5C DDX10 BPTF KAT2B FAT1 SYNE2 SEC16A DYNC1H1 NUP107 ZNF607 TRMT112 PHF12 NUP98 ZNF629 ZBTB14 RAD50 NCOR1 TMED9 ZFHX3 USP54 PSMD14 | 1.34e-08 | 1429 | 211 | 29 | 35140242 | |
| Pubmed | SMG1 GBF1 STAB1 UBR5 RHOBTB2 SYNE2 SEC16A PREX1 SYNE1 TLN1 DIP2C WDFY3 | 1.53e-08 | 225 | 211 | 12 | 12168954 | |
| Pubmed | SART3 SMG1 TRAF3 BCKDK SPTBN1 SPTBN2 TUBGCP2 TNFRSF10A DDB1 FANCD2 CEP170 UBR5 SYNE2 ASCC3 NONO DYNC1H1 SPECC1L RAD50 NBAS MSH6 SF3B1 PLEKHG3 TLN1 ASPH TMED9 NUP188 PSMD14 TBL2 PRPS1 | 1.59e-08 | 1440 | 211 | 29 | 30833792 | |
| Pubmed | PRPS2 SART3 SMG1 SPTA1 SPEF2 SPTBN1 SPTBN2 EML6 ACTN1 PRPS1L1 DDX11 BPTF NRXN3 EFCAB12 SYNE2 NONO PREX1 RPGRIP1 STRN3 SYNE1 PCLO NUP98 CCDC150 NCOR1 SNRNP48 SF3B1 MYH15 SPAG17 PRPS1 | 1.63e-08 | 1442 | 211 | 29 | 35575683 | |
| Pubmed | ZNF423 SPTB SPTBN1 SPTBN2 POGZ ACTN1 STAB1 PIK3R4 NAV3 GPSM2 TAOK1 SPARCL1 SGSM3 PREX1 GOLGA3 DYNC1H1 SESTD1 SYNE1 HECTD4 ADNP2 FRY SNRNP48 SF3B1 RAB11FIP4 WDFY3 USP54 RAPGEF2 | 2.19e-08 | 1285 | 211 | 27 | 35914814 | |
| Pubmed | SART3 POGZ DDB1 TAOK3 ASCC3 GOLGA3 DYNC1H1 NUP107 NUP98 RAD50 SF3B1 CEP250 PRPF38A NUP188 | 2.53e-08 | 340 | 211 | 14 | 29478914 | |
| Pubmed | SART3 ACTN1 DDB1 UBR5 SEC16A DOCK6 DYNC1H1 STRN3 RAD50 VANGL2 MSH6 USO1 TLN1 ASPH PSMD14 | 2.64e-08 | 399 | 211 | 15 | 37536630 | |
| Pubmed | SART3 ZNF148 BCKDK SPTBN1 SPTBN2 ATP6V1F DDB1 DDX10 SBF1 UBR5 SYNE2 ASCC3 ITM2B GOLGA3 FRAS1 FAM184A DRG2 NUP107 TCHP SYNE1 GRSF1 VANGL2 PREB NBAS SF3B1 TLN1 ASPH TBL2 HDLBP | 3.18e-08 | 1487 | 211 | 29 | 33957083 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 TRAF3 GBF1 MCC DDB1 FANCD2 PTPN4 SBF1 UBR5 SEC16A PRMT9 ASCC3 PIPSL NUP98 CPT1A RAD50 VANGL2 MSH6 ASPH NUP188 PSMD14 TBL2 PRPS1 | 3.29e-08 | 974 | 211 | 23 | 28675297 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF148 ZNF423 MECOM POGZ BPTF KAT2B SEC16A PHF12 NUP98 ZBTB14 NCOR1 TBK1 TMED9 ZFHX3 | 3.76e-08 | 351 | 211 | 14 | 38297188 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | BCKDK TUBGCP2 DDB1 DDX10 FANCD2 CEP170 UBR5 ASCC3 DOCK6 GOLGA3 CCHCR1 STRN3 NUP98 RAD50 SNRNP48 GCC2 CEP250 TBK1 USP54 HDLBP | 4.24e-08 | 754 | 211 | 20 | 33060197 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | GBF1 ATR MYO5C SBF1 SEC16A ASCC3 DOCK6 NUP107 SPECC1L NBAS MSH6 | 4.98e-08 | 202 | 211 | 11 | 33005030 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF423 BCKDK SPTBN1 SPTBN2 POGZ DDB1 DHX8 CEP170 BPTF SBF1 DOCK6 NONO DYNC1H1 IL19 DHX16 TRMT112 SYNE1 HECTD4 ZNF629 VANGL2 MSH6 SNRNP48 SF3B1 PRPF38A | 5.24e-08 | 1082 | 211 | 24 | 38697112 |
| Pubmed | 6.23e-08 | 87 | 211 | 8 | 12465718 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 6.30e-08 | 18 | 211 | 5 | 12119179 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TRAF3 ZNF423 BCKDK ACTN1 DDB1 STAB1 MAD1L1 PEX5 GPSM2 SPARCL1 NONO GOLGA3 NOTCH1 NRBF2 PHF12 DGKD MAPK7 | 6.87e-08 | 560 | 211 | 17 | 21653829 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 GBF1 SPTBN1 MELK PIK3R4 CEP170 KSR1 SBF1 DSTYK SYNE2 MAD1L1 SEC16A DOCK6 USP53 DRG2 ZNF629 TRAK1 USO1 PLEKHG3 USP54 RAPGEF2 | 7.89e-08 | 861 | 211 | 21 | 36931259 |
| Pubmed | SART3 GBF1 BCKDK SPTBN1 SPTBN2 POGZ DDB1 DDX10 CEP170 SEC16A TAOK1 ASCC3 PIPSL NONO DYNC1H1 DHX16 DRG2 SPECC1L GRSF1 SF3B1 USO1 TBK1 TLN1 ASPH TMED9 PRPF38A HDLBP | 8.18e-08 | 1371 | 211 | 27 | 36244648 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF148 ATR ACTR5 SPTA1 MECOM POGZ DDB1 DHX8 BPTF ABRAXAS1 NONO NUP107 TRMT112 PHF12 NUP98 ZNF629 CPT1A ZBTB14 RAD50 PREB NCOR1 SF3B1 ASPH PRPF38A NUP188 TBL2 | 9.84e-08 | 1294 | 211 | 26 | 30804502 |
| Pubmed | BCKDK MECOM POGZ CEP170 SEC16A TAOK1 ASCC3 DYNC1H1 DHX16 NUP107 SPECC1L RAD50 MSH6 SF3B1 TBK1 ASPH HDLBP | 1.87e-07 | 601 | 211 | 17 | 33658012 | |
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 1314091 | ||
| Pubmed | ZNF423 POGZ UBR5 RHOBTB2 SEC16A NAV3 DYNC1H1 DHX16 FRAS1 SYNE1 TRAK1 GCC2 TLN1 RAB11FIP4 | 2.30e-07 | 407 | 211 | 14 | 12693553 | |
| Pubmed | 2.41e-07 | 23 | 211 | 5 | 22792062 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.69e-07 | 10 | 211 | 4 | 22159418 | |
| Pubmed | ZNF148 SPTBN2 POGZ ACTN1 CEP170 BPTF SEC16A ASCC3 NONO DYNC1H1 SPECC1L RAD50 NCOR1 MSH6 TLN1 HDLBP | 2.92e-07 | 549 | 211 | 16 | 38280479 | |
| Pubmed | SPTB SPTBN1 CEP170 BPTF SEC16A NONO GOLGA3 DYNC1H1 DHX16 NUP107 NUP98 USO1 TLN1 | 3.63e-07 | 360 | 211 | 13 | 33111431 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | BCKDK ACTN1 DDB1 PRPS1L1 SYNE2 SEC16A TDRD6 SYNE1 RAD50 TLN1 | 3.92e-07 | 197 | 211 | 10 | 20811636 |
| Pubmed | SART3 GBF1 SPTBN1 ACTN1 TUBGCP2 DDB1 ASCC3 NONO DYNC1H1 NUP107 NUP98 RAD50 SF3B1 USO1 TLN1 NUP188 PSMD14 | 4.30e-07 | 638 | 211 | 17 | 33239621 | |
| Pubmed | SART3 ACTR5 BCKDK ACTN1 DHX8 DDX10 SBF1 ASCC3 ITM2B NONO PREX1 STRN3 FAM184A PHF12 SYNE1 SPECC1L GRSF1 PREB MSH6 PLEKHG3 TLN1 ASPH TMED9 ZFHX3 PRPF38A TBL2 HDLBP | 4.63e-07 | 1497 | 211 | 27 | 31527615 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | SYNE2 ASCC3 NOTCH1 FRAS1 NUP98 VANGL2 PREB NBAS MSH6 SF3B1 TLN1 TBL2 HDLBP | 5.75e-07 | 375 | 211 | 13 | 32788342 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPS2 SART3 GBF1 SPTBN1 SPTBN2 HMGCS1 ACTN1 DDB1 CEP170 UBR5 SEC16A ASCC3 NONO DYNC1H1 STRN3 RAD50 MSH6 SF3B1 USO1 TLN1 PSMD14 HDLBP PRPS1 | 6.08e-07 | 1149 | 211 | 23 | 35446349 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | MYO5C UBR5 SEC16A DYNC1H1 HECTD4 GRSF1 NCOR1 SF3B1 NUP188 USP54 PSMD14 | 7.29e-07 | 264 | 211 | 11 | 32814769 |
| Pubmed | ZNF148 ATR FANCD2 UBR5 ABRAXAS1 SAGE1 NONO KNL1 HUS1 PHF12 SPECC1L RAD50 SF3B1 PSMD14 | 8.26e-07 | 453 | 211 | 14 | 29656893 | |
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 8.77e-07 | 4 | 211 | 3 | 3862089 | |
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 8.77e-07 | 4 | 211 | 3 | 12820899 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 21566095 | ||
| Pubmed | SART3 SMG1 POGZ MELK STAB1 NRXN3 SBF1 HECW2 DOCK6 USP53 PHF12 HECTD4 ARHGEF10L VANGL2 NUP188 | 9.74e-07 | 529 | 211 | 15 | 14621295 | |
| Pubmed | SART3 SPTBN1 SPTBN2 ACTN1 DDB1 DDX10 CEP170 SEC16A ZNF629 SPECC1L RAD50 | 1.05e-06 | 274 | 211 | 11 | 34244482 | |
| Pubmed | 1.24e-06 | 89 | 211 | 7 | 18950845 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SART3 ZNF148 POGZ TUBGCP2 DDB1 DDX10 BPTF MAD1L1 DRG2 NUP107 NCOR1 NUP188 | 1.35e-06 | 341 | 211 | 12 | 32971831 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SART3 GBF1 ZNF148 MECOM POGZ BPTF UBR5 MAD1L1 DYNC1H1 NOTCH1 DHX16 NUP107 NRF1 NUP98 RAD50 NCOR1 SF3B1 USO1 TSHZ1 | 1.40e-06 | 857 | 211 | 19 | 25609649 |
| Pubmed | FAT1 UBR5 SEC16A PEX5 GOLGA3 DYNC1H1 NUP107 NUP98 SPECC1L GRSF1 NCOR1 SF3B1 USO1 GCC2 IFFO2 ZFHX3 RAPGEF2 PRPS1 | 1.45e-06 | 777 | 211 | 18 | 35844135 | |
| Pubmed | SPTBN1 TUBGCP2 DDB1 UBR5 NONO GOLGA3 MSH6 SF3B1 GCC2 CEP250 TMED9 NUP188 PSMD14 | 1.47e-06 | 408 | 211 | 13 | 33766124 | |
| Pubmed | 1.62e-06 | 33 | 211 | 5 | 19714462 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPS2 ZNF148 HMGCS1 DDX10 TAOK3 CLK2 SEC16A TAOK1 TP53RK ASCC3 NONO DYNC1H1 DHX16 DRG2 TRMT112 NUP98 GRSF1 NCOR1 MSH6 SF3B1 TMED9 PRPF38A PSMD14 PRPS1 | 1.80e-06 | 1318 | 211 | 24 | 30463901 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPS2 SART3 ACTR5 SPTBN1 ACTN1 DDB1 DHX8 CEP170 UBR5 SYNE2 SEC16A NONO DYNC1H1 TRMT112 WNT11 CPT1A GRSF1 RAD50 MSH6 SF3B1 USO1 TLN1 ASPH HDLBP PRPS1 | 1.85e-06 | 1415 | 211 | 25 | 28515276 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SPTA1 SPTBN1 ACTN1 ACE DDB1 NONO DYNC1H1 SYNE1 PCLO CPT1A NBAS MSH6 TLN1 ZFHX3 SPAG17 PSMD14 HDLBP PRPS1 | 2.46e-06 | 807 | 211 | 18 | 30575818 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SART3 SMG1 SPTBN2 CEP170 SYNE2 SEC16A NONO DRG2 NUP107 PCLO RAD50 MSH6 HDLBP PRPS1 | 2.50e-06 | 498 | 211 | 14 | 36634849 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PRPS2 GBF1 DDB1 DDX11 PIK3R4 UBR5 SEC16A ASCC3 PIPSL NONO DYNC1H1 NUP107 TRMT112 CPT1A PREB NCOR1 MSH6 SF3B1 TMED9 NUP188 PSMD14 TBL2 PRPS1 | 2.76e-06 | 1257 | 211 | 23 | 37317656 |
| Pubmed | 2.91e-06 | 101 | 211 | 7 | 26949739 | ||
| Pubmed | GBF1 SPTBN1 TUBGCP2 DDB1 FANCD2 UBR5 SEC16A NONO GOLGA3 NUP107 MSH6 SF3B1 GCC2 TMED9 NUP188 PSMD14 | 3.02e-06 | 657 | 211 | 16 | 36180527 | |
| Pubmed | 3.10e-06 | 102 | 211 | 7 | 21926972 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 SMG1 CEP170 SBF1 UBR5 SEC16A ASCC3 NUP107 HECTD4 NUP98 MSH6 NUP188 USP54 | 3.36e-06 | 440 | 211 | 13 | 34244565 |
| Pubmed | 3.48e-06 | 147 | 211 | 8 | 16959763 | ||
| Pubmed | 3.50e-06 | 251 | 211 | 10 | 29778605 | ||
| Pubmed | 3.53e-06 | 104 | 211 | 7 | 9205841 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MECOM TUBGCP2 DDX11 UBR5 SEC16A NONO KNL1 NUP107 TCHP ZNF629 RAD50 NCOR1 USO1 TBK1 HDLBP | 3.55e-06 | 588 | 211 | 15 | 38580884 |
| Pubmed | 3.59e-06 | 197 | 211 | 9 | 36604605 | ||
| Pubmed | STAB1 PIK3R4 CLK2 NAV3 SPARCL1 TP53RK GNAT1 NOTCH1 RPGRIP1 WNT11 RBP3 NUP98 ZNF629 ADNP2 CPT1A RGS16 NCOR1 MCM9 WDFY3 PRPS1 | 3.80e-06 | 1006 | 211 | 20 | 15226823 | |
| Pubmed | GBF1 TUBGCP2 CEP170 KSR1 UBR5 SEC16A DOCK6 NOTCH1 STRN3 TCHP TBK1 USP54 RAPGEF2 | 3.89e-06 | 446 | 211 | 13 | 24255178 | |
| Pubmed | ZNF148 HMGCS1 POGZ ACTN1 TUBGCP2 CEP170 BPTF TAOK3 UBR5 NONO DYNC1H1 KNL1 PHF12 ZNF629 RAD50 NCOR1 MSH6 TLN1 PSMD14 HDLBP PRPS1 | 4.20e-06 | 1103 | 211 | 21 | 34189442 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TUBGCP2 DDX10 FANCD2 UBR5 ASCC3 ITM2B DYNC1H1 NUP107 NUP98 CPT1A PREB USO1 TBK1 TLN1 ASPH TMED9 NUP188 TBL2 HDLBP | 5.47e-06 | 942 | 211 | 19 | 31073040 |
| Pubmed | DDB1 CEP170 UBR5 DYNC1H1 NUP107 NUP98 GRSF1 RAD50 MSH6 SF3B1 USO1 NUP188 PSMD14 HDLBP | 5.55e-06 | 534 | 211 | 14 | 35032548 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PABIR1 POGZ PIK3R4 CEP170 KSR1 UBR5 SEC16A PEX5 DOCK6 NONO DHX16 STRN3 SCHIP1 DRG2 TRAK1 TBK1 PRPF38A RAPGEF2 RASSF9 MAPK7 | 6.03e-06 | 1038 | 211 | 20 | 26673895 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 6.51e-06 | 212 | 211 | 9 | 33853758 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SPTBN1 BPTF NONO DYNC1H1 NUP107 RAD50 NCOR1 MSH6 SF3B1 TLN1 HDLBP | 6.63e-06 | 332 | 211 | 11 | 32786267 |
| Pubmed | SART3 DHX8 DDX10 CEP170 ASCC3 DHX16 NUP107 SYNE1 NUP98 PRPF38A NUP188 | 6.63e-06 | 332 | 211 | 11 | 25693804 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | BCKDK DDB1 CEP170 TAOK3 CLK2 ASCC3 NONO TRMT112 SPECC1L CPT1A PREB TBK1 TLN1 TBL2 HDLBP PRPS1 | 6.82e-06 | 701 | 211 | 16 | 30196744 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 6.88e-06 | 271 | 211 | 10 | 32433965 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 DHX8 FANCD2 UBR5 TP53RK ASCC3 DYNC1H1 DHX16 DRG2 RAD50 NBAS MSH6 USO1 PRPF38A NUP188 PSMD14 | 7.19e-06 | 704 | 211 | 16 | 29955894 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | PABIR1 SMG1 NUP62CL STAB1 FAT1 DSTYK TAOK1 ARMH3 GOLGA3 SF3B1 ZNF335 TTLL11 RSKR DNAH11 | 8.07e-06 | 552 | 211 | 14 | 10737800 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPS2 SART3 SPTBN1 SPTBN2 ACTN1 TUBGCP2 DDB1 DHX8 CEP170 ASCC3 NONO DYNC1H1 DHX16 NUP98 SPECC1L RAD50 MSH6 SF3B1 PLEKHG3 ASPH TBL2 HDLBP | 9.25e-06 | 1257 | 211 | 22 | 36526897 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTBN1 SPTBN2 ACTN1 UBR5 DYNC1H1 SESTD1 SYNE1 PCLO SPECC1L RAPGEF2 | 9.44e-06 | 281 | 211 | 10 | 28706196 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.00e-05 | 283 | 211 | 10 | 30585729 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SMG1 GBF1 EML6 CEP170 BPTF SBF1 HECW2 SEC16A HSD11B1 DHX16 GRID1 ZBTB14 | 1.12e-05 | 420 | 211 | 12 | 28065597 |
| Pubmed | GBF1 SPTBN2 LAPTM5 CEP170 DSTYK TAOK1 PREX1 ZNF629 ZNF407 DGKD ZNF526 PLEKHG3 DIP2C | 1.13e-05 | 493 | 211 | 13 | 15368895 | |
| Pubmed | SART3 SMG1 ATR PIK3R4 TAOK3 SBF1 DSTYK DDX11L8 DHX16 FRAS1 ZNF629 PREB TBK1 ASPH GNAT3 | 1.17e-05 | 650 | 211 | 15 | 38777146 | |
| Pubmed | MCC MECOM ATP6V1F TUBGCP2 MELK DDB1 DHX8 CEP170 SEC16A PEX5 KNL1 DRG2 NBAS USO1 USP54 PSMD14 | 1.18e-05 | 733 | 211 | 16 | 34672954 | |
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 25218921 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | PABIR1 MCC DDB1 FANCD2 PTPN4 UBR5 SEC16A DYNC1H1 AMH STRN3 SYNE1 SPECC1L VANGL2 SF3B1 | 1.22e-05 | 573 | 211 | 14 | 28330616 |
| Pubmed | SART3 DDB1 NONO DHX16 FRAS1 DRG2 GRSF1 PREB MSH6 YJU2 SF3B1 USO1 TLN1 TBL2 PRPS1 | 1.23e-05 | 653 | 211 | 15 | 33742100 | |
| Pubmed | 1.39e-05 | 128 | 211 | 7 | 23858473 | ||
| Pubmed | ZNF148 MAD1L1 SEC16A TAOK1 NONO STRN3 NUP107 NUP98 NCOR1 MSH6 SF3B1 GCC2 CTDP1 | 1.40e-05 | 503 | 211 | 13 | 16964243 | |
| Interaction | SIRT7 interactions | SART3 ATR SPTBN1 SPTBN2 POGZ ACTN1 DDB1 DHX8 DDX10 CEP170 BPTF KAT2B SBF1 UBR5 SYNE2 SEC16A ASCC3 DYNC1H1 DHX16 NUP107 NUP98 RAD50 MSH6 SF3B1 TLN1 NUP188 HDLBP | 1.75e-08 | 744 | 210 | 27 | int:SIRT7 |
| Interaction | PHF21A interactions | NUP62CL MECOM DDB1 UBR5 SEC16A ASCC3 GOLGA3 KNL1 CCHCR1 DRG2 NUP107 PHF12 RAD50 USO1 GCC2 TBK1 ZFHX3 | 1.26e-07 | 343 | 210 | 17 | int:PHF21A |
| Interaction | BRCA1 interactions | SART3 GBF1 ZNF148 MAN2C1 ATR ZNF423 SPTBN1 DDB1 FANCD2 CEP170 BPTF UBR5 CLK2 ABRAXAS1 SEC16A PEX5 SAGE1 RPA4 DYNC1H1 KNL1 DNHD1 RPGRIP1 FAM184A NUP107 HUS1 PHF12 ZBTB14 RAD50 MSH6 SF3B1 USO1 TLN1 PSMD14 HDLBP | 2.48e-07 | 1249 | 210 | 34 | int:BRCA1 |
| Interaction | HDAC1 interactions | ZNF148 ATR TNFSF10 ZNF423 MECOM DDB1 FANCD2 BPTF UBR5 SYNE2 MAD1L1 ASCC3 NONO GOLGA3 NOTCH1 KNL1 DRG2 NUP107 HUS1 PHF12 NUP98 TRAK1 RAD50 NCOR1 MSH6 USO1 GCC2 CEP250 TBK1 TLN1 ZFHX3 | 5.04e-07 | 1108 | 210 | 31 | int:HDAC1 |
| Interaction | SQSTM1 interactions | SMG1 TRAF3 GBF1 BCKDK MECOM TUBGCP2 TNFRSF10A MELK CEP170 BPTF GRK2 SEC16A PEX5 TAOK1 ASCC3 RPA4 DYNC1H1 NOTCH1 NRBF2 VANGL2 NCOR1 CEP250 TBK1 ASPH TNK2 PRPF38A NUP188 WDFY3 USP54 RAPGEF2 PSMD14 TRIM44 HDLBP | 8.59e-07 | 1257 | 210 | 33 | int:SQSTM1 |
| Interaction | CDC5L interactions | ATR SPTBN1 MECOM TUBGCP2 MELK DDB1 DHX8 STAB1 FANCD2 UBR5 MAD1L1 NONO RPA4 DYNC1H1 KNL1 DHX16 NUP107 SYNE1 TRAK1 RAD50 MSH6 YJU2 SF3B1 USO1 TLN1 HDLBP | 1.00e-06 | 855 | 210 | 26 | int:CDC5L |
| Interaction | SNW1 interactions | ATR SPTBN1 TUBGCP2 DDB1 DHX8 FANCD2 PIK3R4 UBR5 HECW2 MAD1L1 TAOK1 NONO RPA4 NOTCH1 SPECC1L TRAK1 RAD50 NCOR1 MSH6 YJU2 SF3B1 USO1 TLN1 HDLBP | 1.04e-06 | 747 | 210 | 24 | int:SNW1 |
| Interaction | YWHAG interactions | PABIR1 TRAF3 GBF1 SPTBN1 MCC TNFRSF10A MELK FANCD2 PIK3R4 CEP170 KSR1 PTPN4 SBF1 CLK2 SYNE2 MAD1L1 SEC16A TAOK1 DYNC1H1 CCS USP53 HECTD4 ZNF629 SPECC1L TRAK1 PLEKHG3 GCC2 CEP250 TNK2 USP54 RAPGEF2 MAPK7 | 2.13e-06 | 1248 | 210 | 32 | int:YWHAG |
| Interaction | ATG16L1 interactions | BCKDK TUBGCP2 DDB1 CEP170 TAOK3 CLK2 PEX5 ASCC3 NONO GOLGA3 KNL1 CCHCR1 NUP107 TCHP TRMT112 SPECC1L CPT1A PREB NBAS PLEKHG3 GCC2 CEP250 TBK1 TLN1 TNK2 WDFY3 USP54 TBL2 HDLBP PRPS1 | 3.96e-06 | 1161 | 210 | 30 | int:ATG16L1 |
| Interaction | NINL interactions | TUBGCP2 ACE DDB1 CEP170 UBR5 MAD1L1 NONO DYNC1H1 USP53 CCHCR1 FAM184A TCHP NCOR1 CEP250 TBK1 ZFHX3 USP54 | 6.67e-06 | 458 | 210 | 17 | int:NINL |
| Interaction | PRP4K interactions | PRPS2 DHX8 UBR5 CLK2 RHOBTB2 NONO NRF1 GRSF1 ARHGEF10L MSH6 SF3B1 TBK1 PRPF38A HDLBP | 9.78e-06 | 329 | 210 | 14 | int:PRP4K |
| Interaction | LRRC31 interactions | GBF1 ATR MYO5C SBF1 SEC16A ASCC3 DOCK6 NUP107 SPECC1L NBAS MSH6 | 1.06e-05 | 205 | 210 | 11 | int:LRRC31 |
| Interaction | PMS1 interactions | 1.43e-05 | 105 | 210 | 8 | int:PMS1 | |
| Interaction | FOXJ2 interactions | 2.18e-05 | 81 | 210 | 7 | int:FOXJ2 | |
| Interaction | FBXW7 interactions | SART3 ACTR5 BCKDK SPTBN1 MECOM ATP6V1F POGZ DDB1 DDX10 FANCD2 CEP170 SEC16A TAOK1 ASCC3 NONO DYNC1H1 NOTCH1 DHX16 NUP107 SPECC1L RAD50 NCOR1 MSH6 YJU2 SF3B1 TBK1 ASPH CTDP1 HDLBP | 2.59e-05 | 1215 | 210 | 29 | int:FBXW7 |
| Interaction | KLF3 interactions | ZNF148 ZNF423 MECOM POGZ BPTF KAT2B PHF12 ZBTB14 NCOR1 TMED9 ZFHX3 | 2.86e-05 | 228 | 210 | 11 | int:KLF3 |
| Interaction | YWHAH interactions | PABIR1 GBF1 SPTBN1 MELK FANCD2 PIK3R4 CEP170 KSR1 PTPN4 SBF1 CLK2 SYNE2 MAD1L1 SEC16A TAOK1 DOCK6 USP53 DRG2 HECTD4 ZNF629 SPECC1L TRAK1 PLEKHG3 TBK1 USP54 RAPGEF2 MAPK7 | 3.22e-05 | 1102 | 210 | 27 | int:YWHAH |
| Interaction | WHAMMP3 interactions | 3.55e-05 | 119 | 210 | 8 | int:WHAMMP3 | |
| Interaction | METTL21C interactions | 3.93e-05 | 19 | 210 | 4 | int:METTL21C | |
| Interaction | TPR interactions | SART3 GBF1 MECOM DDB1 FANCD2 BPTF PTPN4 MAD1L1 DYNC1H1 NUP107 NUP98 TBK1 | 4.12e-05 | 281 | 210 | 12 | int:TPR |
| Interaction | CD79B interactions | 4.24e-05 | 122 | 210 | 8 | int:CD79B | |
| Interaction | YWHAZ interactions | PABIR1 GBF1 SPTA1 SPTBN1 SPTBN2 MCC MELK FANCD2 CEP170 KSR1 PTPN4 SBF1 SYNE2 GOLGA3 DYNC1H1 SESTD1 NUP107 HECTD4 ZNF629 TRAK1 NCOR1 SF3B1 PLEKHG3 GCC2 TNK2 WDFY3 USP54 RAPGEF2 MAPK7 PSMD14 | 4.54e-05 | 1319 | 210 | 30 | int:YWHAZ |
| Interaction | TP53BP1 interactions | ATR ACTR5 BCKDK MECOM FANCD2 UBR5 ABRAXAS1 SAGE1 TP53RK NONO NUP107 HUS1 RAD50 SF3B1 MCM9 PRPF38A PSMD14 | 4.62e-05 | 533 | 210 | 17 | int:TP53BP1 |
| Interaction | YWHAE interactions | PABIR1 PRPS2 GBF1 MCC MELK DDB1 FANCD2 PIK3R4 CEP170 KSR1 PTPN4 SBF1 NONO GOLGA3 DYNC1H1 SESTD1 ZNF629 TRAK1 SLC8A1 SF3B1 PLEKHG3 GCC2 CEP250 TBK1 USP54 RAPGEF2 MAPK7 HDLBP PRPS1 | 4.72e-05 | 1256 | 210 | 29 | int:YWHAE |
| Interaction | RICTOR interactions | SART3 CLUAP1 SPTBN1 ACTN1 DDB1 FANCD2 UBR5 SEC16A PREX1 RPA4 DYNC1H1 STRN3 CPT1A NCOR1 SF3B1 USO1 GCC2 TLN1 ASPH CTDP1 HDLBP | 4.74e-05 | 759 | 210 | 21 | int:RICTOR |
| Interaction | KDM1A interactions | ZNF148 MECOM POGZ DDB1 FANCD2 CFAP100 UBR5 SEC16A ASCC3 GOLGA3 NOTCH1 KNL1 DRG2 NRBF2 NUP107 PHF12 RAD50 NCOR1 MSH6 USO1 PLEKHG3 GCC2 TBK1 ZFHX3 | 4.90e-05 | 941 | 210 | 24 | int:KDM1A |
| Interaction | MRE11 interactions | GBF1 ATR SPTA1 MECOM FANCD2 KAT2B RPA4 DHX16 RAD50 MSH6 GCC2 MCM9 | 5.05e-05 | 287 | 210 | 12 | int:MRE11 |
| Interaction | SPTA1 interactions | 5.74e-05 | 94 | 210 | 7 | int:SPTA1 | |
| Interaction | YWHAB interactions | PABIR1 GBF1 SPTBN1 MCC MELK FANCD2 PIK3R4 CEP170 KSR1 PTPN4 CLK2 PRMT9 TAOK1 DYNC1H1 NUP107 HECTD4 ZNF629 TRAK1 RAD50 SLC8A1 PLEKHG3 GCC2 USP54 RAPGEF2 MAPK7 | 5.84e-05 | 1014 | 210 | 25 | int:YWHAB |
| Interaction | TRIM66 interactions | TUBGCP2 FANCD2 CEP170 FAT1 SEC16A NUP107 ZNF629 NUP188 WDFY3 USP54 | 6.04e-05 | 205 | 210 | 10 | int:TRIM66 |
| Interaction | APC interactions | SPTBN1 SPTBN2 ACTN1 UBR5 MAD1L1 NAV3 RPA4 STRN3 NUP107 SYNE1 NUP98 SPECC1L CEP250 ASPH | 6.17e-05 | 389 | 210 | 14 | int:APC |
| Interaction | BRAP interactions | 6.57e-05 | 96 | 210 | 7 | int:BRAP | |
| Interaction | CEP78 interactions | 6.57e-05 | 96 | 210 | 7 | int:CEP78 | |
| Interaction | DCPS interactions | SART3 POGZ DDB1 TAOK3 ASCC3 GOLGA3 DYNC1H1 NUP107 NUP98 RAD50 SF3B1 CEP250 PRPF38A NUP188 | 7.07e-05 | 394 | 210 | 14 | int:DCPS |
| Interaction | EGR2 interactions | 7.92e-05 | 171 | 210 | 9 | int:EGR2 | |
| Interaction | CTTN interactions | SART3 GBF1 MAN2C1 SPTBN1 MYO5C SBF1 NONO RPA4 STRN3 SPECC1L USO1 PLEKHG3 TNK2 MYH15 PRPF38A | 8.00e-05 | 450 | 210 | 15 | int:CTTN |
| Interaction | SPAST interactions | 9.15e-05 | 136 | 210 | 8 | int:SPAST | |
| Interaction | MSH3 interactions | 9.65e-05 | 102 | 210 | 7 | int:MSH3 | |
| Interaction | USP53 interactions | 1.01e-04 | 138 | 210 | 8 | int:USP53 | |
| Interaction | SPART interactions | 1.03e-04 | 103 | 210 | 7 | int:SPART | |
| Interaction | KIF20A interactions | SPTB SPTBN1 SPTBN2 EML6 ACTN1 TUBGCP2 DDB1 STAB1 CEP170 UBR5 SYNE2 SEC16A NAV3 NONO DHX16 SYNE1 PCLO HECTD4 NUP98 SPECC1L SF3B1 CTDP1 GNAT3 PRPF38A USP54 | 1.05e-04 | 1052 | 210 | 25 | int:KIF20A |
| Interaction | CIT interactions | NUP62CL SPTB SPTBN1 SPTBN2 POGZ ACTN1 DDB1 DHX8 DDX10 CEP170 BPTF HECW2 SYNE2 NONO DYNC1H1 DHX16 NUP107 SYNE1 PCLO NUP98 SPECC1L GRSF1 NBAS MSH6 SF3B1 ASPH CTDP1 PRPF38A NUP188 SPAG17 HDLBP | 1.06e-04 | 1450 | 210 | 31 | int:CIT |
| Interaction | YWHAQ interactions | PABIR1 GBF1 SPTA1 SPTB MELK FANCD2 CEP170 KSR1 PTPN4 SBF1 CLK2 TAOK1 DYNC1H1 NUP107 HUS1 HECTD4 ZNF629 SPECC1L TRAK1 SLC8A1 USO1 PLEKHG3 CEP250 TLN1 USP54 RAPGEF2 | 1.07e-04 | 1118 | 210 | 26 | int:YWHAQ |
| Interaction | SIRT6 interactions | SART3 SMG1 ACTN1 DDB1 CEP170 FAT1 SBF1 UBR5 SEC16A ASCC3 NUP107 HUS1 HECTD4 NUP98 RAD50 MSH6 NUP188 USP54 | 1.08e-04 | 628 | 210 | 18 | int:SIRT6 |
| Interaction | SLX4 interactions | POGZ DDB1 FANCD2 UBR5 ASCC3 NONO RPA4 DYNC1H1 DHX16 ZNF629 RAD50 NCOR1 MSH6 SF3B1 MCM9 NUP188 HDLBP | 1.09e-04 | 572 | 210 | 17 | int:SLX4 |
| Interaction | NDC80 interactions | MYO5C SYNE2 MAD1L1 NONO GOLGA3 KNL1 CCHCR1 TCHP RAD50 GCC2 CEP250 TBK1 | 1.12e-04 | 312 | 210 | 12 | int:NDC80 |
| Interaction | AGR2 interactions | NUP62CL SPTA1 SPTBN1 POGZ ACTN1 ACE DDB1 GPSM2 NONO DYNC1H1 NRF1 SYNE1 PCLO CPT1A NBAS MSH6 TLN1 ASPH ZFHX3 SPAG17 PSMD14 HDLBP PRPS1 | 1.20e-04 | 934 | 210 | 23 | int:AGR2 |
| Interaction | STK38 interactions | TRAF3 GBF1 FANCD2 RHOBTB2 SEC16A DYNC1H1 NOTCH1 CTDP1 PSMD14 | 1.27e-04 | 182 | 210 | 9 | int:STK38 |
| Interaction | PPP1CA interactions | TRAF3 ATR MECOM DDB1 MYO5C FANCD2 CEP170 UBR5 NONO PREX1 RPA4 DYNC1H1 KNL1 RASSF10 RAD50 NCOR1 SF3B1 CTDP1 RASSF9 | 1.31e-04 | 696 | 210 | 19 | int:PPP1CA |
| Interaction | CEP170 interactions | CLUAP1 TRAF3 CEP170 DSTYK SYNE2 ASCC3 RPA4 DRG2 TCHP CEP250 TNK2 HDLBP | 1.34e-04 | 318 | 210 | 12 | int:CEP170 |
| Interaction | TOP3B interactions | GBF1 SPTB SPTBN2 ACTN1 ZNF236 FAT1 SBF1 MAD1L1 SEC16A DOCK6 PREX1 DYNC1H1 NOTCH1 FRAS1 NRF1 PHF12 HECTD4 GRID1 GRSF1 RGS16 ARHGEF10L TRAK1 NCOR1 ZNF335 TLN1 CTDP1 DIP2C TNK2 NUP188 WDFY3 HDLBP | 1.35e-04 | 1470 | 210 | 31 | int:TOP3B |
| Interaction | STIP1 interactions | SART3 GBF1 BCKDK SPTBN1 ACTN1 TUBGCP2 DDB1 FANCD2 PIK3R4 SBF1 ASCC3 NONO RPA4 DYNC1H1 NUP107 NUP98 ARHGEF10L RAD50 SF3B1 USO1 TBK1 TLN1 NUP188 PSMD14 | 1.37e-04 | 1006 | 210 | 24 | int:STIP1 |
| Interaction | TRIM10 interactions | 1.39e-04 | 48 | 210 | 5 | int:TRIM10 | |
| Interaction | LUC7L3 interactions | 1.44e-04 | 185 | 210 | 9 | int:LUC7L3 | |
| Interaction | CDH5 interactions | 1.46e-04 | 109 | 210 | 7 | int:CDH5 | |
| Interaction | TRAIP interactions | 1.53e-04 | 77 | 210 | 6 | int:TRAIP | |
| Interaction | RAB5A interactions | PRPS2 GBF1 FANCD2 PIK3R4 SYNE2 SEC16A PRMT9 SGSM3 ITM2B GOLGA3 DYNC1H1 NOTCH1 VANGL2 NCOR1 SLC9A3 ASPH PSMD14 HDLBP PRPS1 | 1.57e-04 | 706 | 210 | 19 | int:RAB5A |
| Interaction | CHAMP1 interactions | 1.65e-04 | 148 | 210 | 8 | int:CHAMP1 | |
| Interaction | FMR1 interactions | SMG1 SPTBN1 MCC FANCD2 CEP170 DYNC1H1 SRA1 DGKD GRSF1 RAD50 VANGL2 NCOR1 TBK1 WDFY3 RAPGEF2 HDLBP | 1.66e-04 | 536 | 210 | 16 | int:FMR1 |
| Interaction | SLFN11 interactions | DDB1 DHX8 BPTF HFM1 NONO NOTCH1 NUP107 HECTD4 NUP98 SPECC1L RAD50 SF3B1 HDLBP | 1.68e-04 | 376 | 210 | 13 | int:SLFN11 |
| Interaction | CSNK2A1 interactions | SART3 GBF1 SPTBN1 MECOM ACE DDB1 CEP170 PTPN4 KAT2B CLK2 HECW2 DHX16 NRF1 HUS1 NUP98 RASSF10 NCOR1 MSH6 SF3B1 CTDP1 PRPF38A USP54 HDLBP | 1.68e-04 | 956 | 210 | 23 | int:CSNK2A1 |
| Interaction | VWA5A interactions | 1.70e-04 | 50 | 210 | 5 | int:VWA5A | |
| Interaction | CEP43 interactions | 1.76e-04 | 190 | 210 | 9 | int:CEP43 | |
| Interaction | KLF8 interactions | ZNF148 ACTR5 MECOM POGZ BPTF KAT2B SEC16A SGSM3 TRMT112 PHF12 ZBTB14 PSMD14 | 1.83e-04 | 329 | 210 | 12 | int:KLF8 |
| Interaction | RPS6KL1 interactions | 1.86e-04 | 51 | 210 | 5 | int:RPS6KL1 | |
| Interaction | CORO1B interactions | 1.91e-04 | 192 | 210 | 9 | int:CORO1B | |
| Interaction | OBSL1 interactions | SPTBN2 ACTN1 DDB1 DHX8 DDX10 SYNE2 PIPSL NONO GOLGA3 DYNC1H1 DHX16 NUP107 SYNE1 PCLO NUP98 GRSF1 RAD50 SF3B1 TLN1 ASPH NUP188 HDLBP | 1.94e-04 | 902 | 210 | 22 | int:OBSL1 |
| Interaction | TUBG1 interactions | SMG1 ATR SPTBN1 TUBGCP2 DHX8 FANCD2 UBR5 HECW2 SEC16A TCHP CPT1A CEP250 TRIM44 | 1.96e-04 | 382 | 210 | 13 | int:TUBG1 |
| Interaction | GPR17 interactions | GBF1 ATR TUBGCP2 FANCD2 PIK3R4 GRK2 DSTYK PRMT9 NBAS USO1 WDFY3 | 1.97e-04 | 283 | 210 | 11 | int:GPR17 |
| Interaction | RMC1 interactions | 1.98e-04 | 152 | 210 | 8 | int:RMC1 | |
| Interaction | TOPBP1 interactions | 2.27e-04 | 117 | 210 | 7 | int:TOPBP1 | |
| Interaction | PCNT interactions | PRPS2 SPTBN1 SPTBN2 TUBGCP2 PIPSL FAM184A TCHP SYNE1 USO1 PSMD14 | 2.28e-04 | 241 | 210 | 10 | int:PCNT |
| Interaction | CHMP4B interactions | TRAF3 SPTB SPTBN1 SPTBN2 ACTN1 DDB1 CEP170 UBR5 NONO RPA4 NUP98 SPECC1L SF3B1 MSLNL PLEKHG3 CTDP1 GNAT3 PRPF38A HDLBP | 2.28e-04 | 727 | 210 | 19 | int:CHMP4B |
| Interaction | SHANK3 interactions | TRAF3 SPTBN1 SPTBN2 ACTN1 DDB1 DYNC1H1 NOTCH1 DRG2 NRBF2 PHF12 SYNE1 USO1 ZFHX3 RAPGEF2 PSMD14 | 2.32e-04 | 496 | 210 | 15 | int:SHANK3 |
| Interaction | POLH interactions | 2.46e-04 | 84 | 210 | 6 | int:POLH | |
| Interaction | TERF2 interactions | BCKDK ACTN1 DDB1 PRPS1L1 SYNE2 SEC16A TDRD6 ARMH3 SYNE1 RAD50 SF3B1 TLN1 | 2.48e-04 | 340 | 210 | 12 | int:TERF2 |
| Interaction | NUP50 interactions | SART3 ZNF148 DHX8 FANCD2 TP53RK RPA4 DHX16 NUP107 NUP98 ZNF629 NCOR1 YJU2 | 2.55e-04 | 341 | 210 | 12 | int:NUP50 |
| Interaction | BRD1 interactions | ZNF148 MCC FANCD2 KSR1 UBR5 HSD11B1 ASCC3 ZNF629 RAD50 ZNF526 TBK1 NUP188 | 2.76e-04 | 344 | 210 | 12 | int:BRD1 |
| Interaction | FXR1 interactions | SMG1 TRAF3 ZNF423 BCKDK ACTN1 FANCD2 CEP170 SBF1 MAD1L1 SEC16A GPSM2 NONO RPA4 GOLGA3 NCOR1 TBK1 MAPK7 HDLBP | 2.82e-04 | 679 | 210 | 18 | int:FXR1 |
| Interaction | KCTD13 interactions | SART3 SPTA1 SPTB SPTBN1 SPTBN2 ACTN1 DDB1 PIK3R4 CEP170 GRK2 SBF1 HECW2 SEC16A GOLGA3 DYNC1H1 STRN3 SYNE1 PCLO RBP3 SPECC1L SLC1A2 SF3B1 USO1 TLN1 TMED9 USP54 RAPGEF2 DNAH11 HDLBP | 2.85e-04 | 1394 | 210 | 29 | int:KCTD13 |
| Interaction | MUTYH interactions | 2.89e-04 | 31 | 210 | 4 | int:MUTYH | |
| Interaction | CHEK2 interactions | 3.06e-04 | 250 | 210 | 10 | int:CHEK2 | |
| Interaction | SRRM1 interactions | DHX8 UBR5 CLK2 RHOBTB2 SYNE2 NONO DYNC1H1 DHX16 GRSF1 ARHGEF10L SF3B1 HDLBP | 3.06e-04 | 348 | 210 | 12 | int:SRRM1 |
| Interaction | PML interactions | SART3 ZNF148 ATR PDSS1 SPTA1 ACTN1 FANCD2 CEP170 UBR5 SYNE2 MAD1L1 SEC16A NONO KNL1 SLC1A2 RAD50 NCOR1 USO1 TLN1 MAPK7 PSMD14 HDLBP | 3.09e-04 | 933 | 210 | 22 | int:PML |
| Interaction | PTPN1 interactions | ATP6V1F ACTN1 DDB1 FANCD2 CLK2 RHOBTB2 SYNE2 SEC16A PEX5 GOLGA3 DYNC1H1 NUP107 NUP98 RAD50 VANGL2 PREB NBAS | 3.10e-04 | 625 | 210 | 17 | int:PTPN1 |
| Interaction | NUP43 interactions | ACTR5 POGZ DDB1 DHX8 FANCD2 BPTF UBR5 SYNE2 TP53RK KNL1 NUP107 PHF12 NUP98 NCOR1 CEP250 ZFHX3 RAPGEF2 | 3.10e-04 | 625 | 210 | 17 | int:NUP43 |
| Interaction | BIRC3 interactions | SART3 TRAF3 ATR SPTBN1 POGZ DDB1 DDX10 FANCD2 TDRD6 ITM2B NONO DYNC1H1 DHX16 DNHD1 NUP107 SYNE1 NUP98 GRSF1 RAD50 MSH6 SF3B1 USO1 TLN1 TMED9 NUP188 PSMD14 HDLBP PRPS1 | 3.17e-04 | 1334 | 210 | 28 | int:BIRC3 |
| Interaction | MAD2L1 interactions | 3.26e-04 | 252 | 210 | 10 | int:MAD2L1 | |
| Interaction | MAPRE1 interactions | SPTBN1 ACTN1 PIK3R4 CEP170 KAT2B SEC16A NAV3 NONO RPA4 DYNC1H1 NUP107 NUP98 SPECC1L GCC2 CEP250 | 3.38e-04 | 514 | 210 | 15 | int:MAPRE1 |
| Interaction | ENAH interactions | 3.58e-04 | 126 | 210 | 7 | int:ENAH | |
| Interaction | SCOC interactions | 3.71e-04 | 59 | 210 | 5 | int:SCOC | |
| Interaction | KAT5 interactions | SPTBN1 MCC FANCD2 PTPN4 NONO NOTCH1 ZBTB14 RAD50 ZNF526 YJU2 SF3B1 TNK2 | 3.95e-04 | 358 | 210 | 12 | int:KAT5 |
| Interaction | NIN interactions | TUBGCP2 FANCD2 CEP170 DYNC1H1 CCHCR1 FAM184A HUS1 TCHP CEP250 TBK1 IFFO2 USP54 | 4.05e-04 | 359 | 210 | 12 | int:NIN |
| Interaction | HSPB1 interactions | CLUAP1 SPTBN1 MECOM ACTN1 RBM48 FANCD2 SBF1 SEC16A DYNC1H1 CCHCR1 PHF12 NBAS MSH6 BICDL1 RASSF9 MAPK7 PSMD14 HDLBP | 4.63e-04 | 708 | 210 | 18 | int:HSPB1 |
| Interaction | MSH2 interactions | 4.64e-04 | 313 | 210 | 11 | int:MSH2 | |
| Interaction | SUMO2 interactions | SPTBN1 POGZ FANCD2 BPTF ABRAXAS1 MAD1L1 NONO DYNC1H1 NUP107 RAD50 NCOR1 MSH6 SF3B1 TBK1 TLN1 HDLBP | 4.91e-04 | 591 | 210 | 16 | int:SUMO2 |
| Interaction | NUDCD1 interactions | 5.04e-04 | 63 | 210 | 5 | int:NUDCD1 | |
| Interaction | TRAF3IP1 interactions | 5.07e-04 | 96 | 210 | 6 | int:TRAF3IP1 | |
| Interaction | NUDT21 interactions | RBM48 DHX8 FANCD2 NONO RPA4 DHX16 NUP98 RAD50 SF3B1 PLEKHG3 PRPF38A HDLBP | 5.17e-04 | 369 | 210 | 12 | int:NUDT21 |
| Interaction | SNCA interactions | SART3 SMG1 MAN2C1 SPTBN1 KAT2B GRK2 SYNE2 SEC16A SGSM3 NONO DYNC1H1 DRG2 NUP107 PCLO RAD50 MSH6 HDLBP PRPS1 | 5.28e-04 | 716 | 210 | 18 | int:SNCA |
| GeneFamily | EF-hand domain containing|Spectrins | 1.05e-07 | 7 | 136 | 4 | 1113 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 ZNF148 ZNF423 MECOM ZNF236 ZNF81 ZNF607 ZNF629 ADNP2 ZNF407 ZBTB14 ZFY ZNF526 ZNF335 ZFHX3 TSHZ1 | 1.00e-04 | 718 | 136 | 16 | 28 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.68e-04 | 206 | 136 | 8 | 682 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.77e-04 | 15 | 136 | 3 | 529 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.34e-04 | 4 | 136 | 2 | 1252 | |
| GeneFamily | Nucleoporins | 1.76e-03 | 32 | 136 | 3 | 1051 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.43e-03 | 10 | 136 | 2 | 1178 | |
| GeneFamily | Ras association domain family | 2.43e-03 | 10 | 136 | 2 | 1198 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.48e-03 | 36 | 136 | 3 | 823 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.95e-03 | 11 | 136 | 2 | 1168 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 ZNF148 ATR MECOM MELK DDX10 PIK3R4 CEP170 BPTF PTPN4 TAOK3 FAT1 UBR5 SYNE2 MAD1L1 NAV3 ASCC3 STRN3 SCHIP1 NUP98 SPECC1L TRAK1 NBAS MSH6 GCC2 ZFHX3 WDFY3 RAPGEF2 TRIM44 | 6.85e-11 | 856 | 211 | 29 | M4500 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | TRAF3 ZNF148 MAN2C1 CLK2 SEC16A TAOK1 PREX1 DHX16 ZBTB14 NCOR1 TNK2 RAPGEF2 | 8.32e-08 | 199 | 211 | 12 | M9443 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 ZNF148 ATR SPEF2 ITGA1 LAPTM5 BPTF PTPN4 KAT2B TAOK3 GRK2 UBR5 DSTYK TAOK1 ASCC3 ITM2B NONO PREX1 DYNC1H1 NOTCH1 TRMT112 SYNE1 HECTD4 NUP98 IFI44 RGS16 NCOR1 SF3B1 TBK1 TLN1 TNK2 | 1.22e-06 | 1492 | 211 | 31 | M40023 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | GBF1 TNFSF10 HMGCS1 RBM48 CLK2 SYNE2 PEX5 SGSM3 DOCK6 NONO CCHCR1 SYNE1 RAD50 NBAS CEP250 CTDP1 NUP188 | 3.86e-06 | 567 | 211 | 17 | M16909 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN | 5.50e-06 | 200 | 211 | 10 | M5212 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZNF148 ATR MELK CEP170 BPTF FAT1 UBR5 ASCC3 STRN3 SCHIP1 NUP98 SPECC1L TRAK1 RAPGEF2 | 2.76e-05 | 466 | 211 | 14 | M13522 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | GBF1 SPTBN1 PEX5 TAOK1 NOTCH1 STRN3 FRAS1 ADNP2 ZBTB14 VANGL2 NCOR1 SLC8A1 GCC2 ZFHX3 | 2.82e-05 | 467 | 211 | 14 | M1347 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 3.07e-05 | 195 | 211 | 9 | M13736 | |
| Coexpression | GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP | 3.32e-05 | 197 | 211 | 9 | M7670 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SART3 ZNF148 POGZ PIK3R4 CEP170 BPTF FAT1 UBR5 NAV3 WDFY3 RAPGEF2 | 3.45e-05 | 300 | 211 | 11 | M8702 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | GBF1 SPTBN1 PEX5 TAOK1 NOTCH1 STRN3 FRAS1 ADNP2 ZBTB14 VANGL2 NCOR1 SLC8A1 GCC2 ZFHX3 | 4.16e-05 | 484 | 211 | 14 | MM999 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | ITGA1 MYO5C LAPTM5 STAB1 NAV3 DSE SYNE1 PCLO PLEKHG3 ASPH TSHZ1 RASSF9 | 6.81e-05 | 382 | 211 | 12 | M45756 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TNFSF10 SPEF2 SPTBN1 MECOM ACE BPTF UBR5 SYNE2 SPARCL1 DOCK6 NOTCH1 TNK2 | 2.33e-10 | 200 | 211 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | SPTBN1 ITGA1 ACE FAT1 HECW2 SPARCL1 ITM2B PREX1 SYNE1 FRY PLXNC1 | 1.74e-09 | 188 | 211 | 11 | 88b3415e33db81726dd29c1f50c886e057af50a0 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 184 | 211 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 184 | 211 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 184 | 211 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.40e-08 | 188 | 211 | 10 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TNFSF10 ZNF423 SPTBN1 MCC ITGA1 NRXN3 HECW2 NAV3 SPARCL1 DOCK6 | 3.07e-08 | 193 | 211 | 10 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ACTN1 ITGA1 CSMD2 FAT1 SPARCL1 SYNE1 SLC8A1 PLEKHG3 ZFHX3 NPAS4 | 4.30e-08 | 200 | 211 | 10 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 SPEF2 SPTBN1 MECOM ACE BPTF SYNE2 SPARCL1 DOCK6 TNK2 | 4.30e-08 | 200 | 211 | 10 | a2b9d1cd291d17abddc3ee2e242121412c864b8b |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-07 | 180 | 211 | 9 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 2.98e-07 | 188 | 211 | 9 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.12e-07 | 189 | 211 | 9 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.12e-07 | 189 | 211 | 9 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-07 | 193 | 211 | 9 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-07 | 194 | 211 | 9 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 4.24e-07 | 196 | 211 | 9 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DCDC1 SPEF2 CFAP100 EFCAB12 SYNE2 FAM184A SYNE1 SPAG17 DNAH11 | 4.42e-07 | 197 | 211 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-07 | 200 | 211 | 9 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.60e-07 | 157 | 211 | 8 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | normal_Lung-Endothelial_cells-EPCs|normal_Lung / Location, Cell class and cell subclass | 2.03e-06 | 176 | 211 | 8 | 71d1bd425772d89d8c550b909e0ec0e36ff22a7e | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-06 | 177 | 211 | 8 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-06 | 178 | 211 | 8 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-06 | 180 | 211 | 8 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-06 | 180 | 211 | 8 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.50e-06 | 181 | 211 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 186 | 211 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-06 | 186 | 211 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 187 | 211 | 8 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.31e-06 | 188 | 211 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 189 | 211 | 8 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | LAM-Endothelial-VasEndo-1|LAM / Condition, Lineage and Cell class | 3.44e-06 | 189 | 211 | 8 | 454e64b1ee93edebbc1576fbf7c3a6db332fa927 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 189 | 211 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 190 | 211 | 8 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.58e-06 | 190 | 211 | 8 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 190 | 211 | 8 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.72e-06 | 191 | 211 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 3.87e-06 | 192 | 211 | 8 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.87e-06 | 192 | 211 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 192 | 211 | 8 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.87e-06 | 192 | 211 | 8 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-06 | 193 | 211 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.02e-06 | 193 | 211 | 8 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.02e-06 | 193 | 211 | 8 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.02e-06 | 193 | 211 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.18e-06 | 194 | 211 | 8 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.18e-06 | 194 | 211 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-06 | 194 | 211 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.34e-06 | 195 | 211 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.34e-06 | 195 | 211 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.34e-06 | 195 | 211 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-06 | 195 | 211 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-06 | 196 | 211 | 8 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.51e-06 | 196 | 211 | 8 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 196 | 211 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 4.68e-06 | 197 | 211 | 8 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.68e-06 | 197 | 211 | 8 | 86591849476b3925857a82b6913f65e74df200c1 | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.85e-06 | 198 | 211 | 8 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-06 | 198 | 211 | 8 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-06 | 198 | 211 | 8 | 9ecf944984aade1bf902e3a92ea4d46a3696822f | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.85e-06 | 198 | 211 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.04e-06 | 199 | 211 | 8 | 9364199c5b4540ce2e14341fd9d504b695f8249d | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 5.04e-06 | 199 | 211 | 8 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|normal_Lung / Location, Cell class and cell subclass | 5.04e-06 | 199 | 211 | 8 | 1ae0b47fade7b1cd74c0faabcf4f12f56f62264e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.04e-06 | 199 | 211 | 8 | 82758d0cee9387d002e3f68a6faa324134fb7564 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.04e-06 | 199 | 211 | 8 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.04e-06 | 199 | 211 | 8 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.04e-06 | 199 | 211 | 8 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-06 | 199 | 211 | 8 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.04e-06 | 199 | 211 | 8 | 5f67ea58512856cbdcef759088a5869720a947a8 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.04e-06 | 199 | 211 | 8 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-06 | 200 | 211 | 8 | d36236c7703b759309c8347f44900fc4bed377f0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-06 | 200 | 211 | 8 | b91f8eb67752a77e1e08e462e50f1b5923695e1b | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-06 | 200 | 211 | 8 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | distal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-06 | 200 | 211 | 8 | e12598a097dd9c4cbf9bb85bfa3057722ef73ad5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-06 | 200 | 211 | 8 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | distal-1-Endothelial-Capillary_Aerocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-06 | 200 | 211 | 8 | 59bacd738433cec6d05624a25fdfc087fb3ca3b5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 163 | 211 | 7 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 1.46e-05 | 166 | 211 | 7 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 169 | 211 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-05 | 170 | 211 | 7 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 2.21e-05 | 177 | 211 | 7 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.21e-05 | 177 | 211 | 7 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-05 | 178 | 211 | 7 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.46e-05 | 180 | 211 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 180 | 211 | 7 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 180 | 211 | 7 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.23e-05 | 49 | 127 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | testosterone enanthate | PRPS2 SART3 SMG1 CLUAP1 ZNF148 TNFSF10 LAPTM5 BPTF PTPN4 GPSM2 CCS CCHCR1 STRN3 ADNP2 RAD50 SF3B1 CTDP1 TSHZ1 RAPGEF2 | 1.53e-06 | 575 | 208 | 19 | ctd:C004648 |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | TRAF3 SPTBN1 MCC RBM48 NPFFR1 ITM2B HUS1 TRAK1 MSH6 ASPH NUP188 | 2.01e-06 | 196 | 208 | 11 | 7186_UP |
| Drug | ADPribulose | 4.54e-06 | 13 | 208 | 4 | CID000197570 | |
| Drug | 2-furfurylthiol | 7.41e-06 | 5 | 208 | 3 | CID000007363 | |
| Drug | PRODAN | 8.54e-06 | 15 | 208 | 4 | CID000028127 | |
| Drug | plakin | 1.02e-05 | 82 | 208 | 7 | CID000018752 | |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 1.13e-05 | 16 | 208 | 4 | CID000107729 | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.14e-05 | 192 | 208 | 10 | 6875_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | SPTBN2 ACE SGSM3 DOCK6 TRAK1 SLC9A3 PLXNC1 PLEKHG3 TLN1 MAPK7 | 1.30e-05 | 195 | 208 | 10 | 4199_DN |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | GBF1 ACTR5 SPTBN1 HMGCS1 RBM48 GRK2 HUS1 PLEKHG3 CTDP1 RAPGEF2 | 1.36e-05 | 196 | 208 | 10 | 7423_UP |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | HMGCS1 NPFFR1 SGSM3 DOCK6 NOTCH1 IFI44 ASPH TNK2 WDFY3 MAPK7 | 1.36e-05 | 196 | 208 | 10 | 5757_DN |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.43e-05 | 197 | 208 | 10 | 5100_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | TRAF3 NUP62CL POGZ TUBGCP2 DSTYK SGSM3 NRF1 TRAK1 ZNF335 ASPH | 1.43e-05 | 197 | 208 | 10 | 5025_DN |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.43e-05 | 197 | 208 | 10 | 5766_DN | |
| Drug | methyl iodoacetate | 1.47e-05 | 6 | 208 | 3 | CID006429536 | |
| Drug | APP-MP | 1.47e-05 | 6 | 208 | 3 | CID003081102 | |
| Drug | pyrimidine-5-nucleotide | 1.47e-05 | 6 | 208 | 3 | CID000440040 | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.49e-05 | 198 | 208 | 10 | 4750_DN | |
| Drug | 3-aminobenzamide; Down 200; 10000uM; MCF7; HG-U133A | 1.56e-05 | 199 | 208 | 10 | 590_DN | |
| Drug | 4-(fluoromethyl)phenyl phosphate | 1.87e-05 | 18 | 208 | 4 | CID000192584 | |
| Drug | AC1NQGJV | 3.69e-05 | 68 | 208 | 6 | CID005195973 | |
| Drug | 2,3-DPG | 3.87e-05 | 137 | 208 | 8 | CID000000061 | |
| Drug | AC1L1HCM | 4.35e-05 | 22 | 208 | 4 | CID000004072 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | 7.42e-05 | 193 | 208 | 9 | 2561_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | 7.42e-05 | 193 | 208 | 9 | 4488_DN | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; HL60; HG-U133A | 7.72e-05 | 194 | 208 | 9 | 1416_DN | |
| Drug | AC1L9K72 | MAN2C1 SPTA1 SPTB SPTBN1 SPTBN2 GRK2 GNAT1 GNAT2 DGKD CPT1A DGKI | 7.80e-05 | 290 | 208 | 11 | CID000446872 |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 8.03e-05 | 195 | 208 | 9 | 1163_DN | |
| Drug | isocamphane | 8.31e-05 | 2 | 208 | 2 | CID000296894 | |
| Drug | AC1NAQHG | 8.31e-05 | 2 | 208 | 2 | CID004481062 | |
| Drug | diethyl acetylenedicarboxylate | 8.31e-05 | 2 | 208 | 2 | CID000069803 | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 1294_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 7173_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 5765_DN | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 3682_UP | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; PC3; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 5833_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 4949_DN | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 8.69e-05 | 197 | 208 | 9 | 4666_DN | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 8.69e-05 | 197 | 208 | 9 | 5057_UP | |
| Drug | SB 203580; Up 200; 1uM; PC3; HT_HG-U133A | 8.69e-05 | 197 | 208 | 9 | 7066_UP | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 8.69e-05 | 197 | 208 | 9 | 5453_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; HL60; HT_HG-U133A | 9.03e-05 | 198 | 208 | 9 | 1839_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 9.03e-05 | 198 | 208 | 9 | 3681_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 9.03e-05 | 198 | 208 | 9 | 6681_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 9.03e-05 | 198 | 208 | 9 | 5467_DN | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; MCF7; HT_HG-U133A | 9.03e-05 | 198 | 208 | 9 | 6878_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 9.38e-05 | 199 | 208 | 9 | 6410_UP | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; HL60; HT_HG-U133A | 9.75e-05 | 200 | 208 | 9 | 2948_DN | |
| Drug | Dithallium chromate | 1.34e-04 | 29 | 208 | 4 | CID000061626 | |
| Disease | Intellectual Disability | BCKDK MCC POGZ BPTF RHOBTB2 TAOK1 ASCC3 DYNC1H1 SYNE1 SPECC1L SLC1A2 FRY ZNF526 ZNF335 SERAC1 | 5.90e-07 | 447 | 204 | 15 | C3714756 |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.30e-06 | 4 | 204 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.14e-05 | 152 | 204 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.78e-05 | 8 | 204 | 3 | DOID:1858 (implicated_via_orthology) | |
| Disease | tea consumption measurement | 3.34e-05 | 129 | 204 | 7 | EFO_0010091 | |
| Disease | Developmental delay (disorder) | 1.23e-04 | 37 | 204 | 4 | C0424605 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 1.42e-04 | 3 | 204 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Hereditary elliptocytosis | 2.83e-04 | 4 | 204 | 2 | cv:C0013902 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.83e-04 | 4 | 204 | 2 | cv:CN293514 | |
| Disease | Macrostomia | 2.83e-04 | 4 | 204 | 2 | C0024433 | |
| Disease | Stomach Carcinoma | 3.95e-04 | 21 | 204 | 3 | C0699791 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 4.55e-04 | 22 | 204 | 3 | EFO_0004741, EFO_0004742 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.69e-04 | 5 | 204 | 2 | C1450051 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 4.69e-04 | 5 | 204 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 4.69e-04 | 5 | 204 | 2 | cv:C0037889 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.69e-04 | 5 | 204 | 2 | C0410190 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 4.69e-04 | 5 | 204 | 2 | C0221409 | |
| Disease | Malignant neoplasm of breast | MAN2C1 TNFSF10 MECOM DDX10 PIK3R4 ABRAXAS1 SYNE2 HSD11B1 NOTCH1 SYNE1 NUP98 CPT1A NCOR1 MSH6 DIP2C USP54 HDLBP PRPS1 | 5.09e-04 | 1074 | 204 | 18 | C0006142 |
| Disease | Adenocarcinoma of large intestine | 5.52e-04 | 96 | 204 | 5 | C1319315 | |
| Disease | HDL cholesterol change measurement | 5.92e-04 | 24 | 204 | 3 | EFO_0007805 | |
| Disease | serum gamma-glutamyl transferase measurement | CLUAP1 TRAF3 MCC ITGA1 TNFRSF10A STAB1 BPTF KAT2B AMH NRBF2 HECTD4 SPECC1L TLN1 TSHZ1 TBL2 HDLBP | 6.59e-04 | 914 | 204 | 16 | EFO_0004532 |
| Disease | breast cancer (implicated_via_orthology) | 6.69e-04 | 25 | 204 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.01e-04 | 6 | 204 | 2 | cv:C0410189 | |
| Disease | Adams Oliver syndrome | 7.01e-04 | 6 | 204 | 2 | C0265268 | |
| Disease | Herpetic meningoencephalitis | 7.01e-04 | 6 | 204 | 2 | C0019385 | |
| Disease | Congenital defect of skull and scalp | 7.01e-04 | 6 | 204 | 2 | C2931779 | |
| Disease | Elliptocytosis, Hereditary | 7.01e-04 | 6 | 204 | 2 | C0013902 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.01e-04 | 6 | 204 | 2 | C0410189 | |
| Disease | Adams-Oliver syndrome 1 | 7.01e-04 | 6 | 204 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 7.01e-04 | 6 | 204 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Weight Gain | 7.28e-04 | 102 | 204 | 5 | C0043094 | |
| Disease | unipolar depression | BNC2 DCDC1 MCC BPTF TAOK3 FAT1 SYNE2 MAD1L1 ASCC3 CCS PCLO GRID1 SHISA9 NBAS SF3B1 PLXNC1 MCM9 ZFHX3 TRIM44 | 7.50e-04 | 1206 | 204 | 19 | EFO_0003761 |
| Disease | unipolar depression, bipolar disorder | 7.80e-04 | 156 | 204 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 7.99e-04 | 60 | 204 | 4 | C4722327 | |
| Disease | risk-taking behaviour | BNC2 DCDC1 ZNF423 BPTF NRXN3 DSTYK MAD1L1 ASCC3 RASSF10 MSH6 DGKI ZFHX3 RAB11FIP4 NPAS4 | 9.26e-04 | 764 | 204 | 14 | EFO_0008579 |
| Disease | hearing threshold measurement | 9.39e-04 | 28 | 204 | 3 | EFO_0007618 | |
| Disease | Herpes encephalitis | 9.76e-04 | 7 | 204 | 2 | C0276226 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.76e-04 | 7 | 204 | 2 | C0751337 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.06e-03 | 227 | 204 | 7 | EFO_0004346, EFO_0010736 | |
| Disease | obsolete_red blood cell distribution width | ATR SPTA1 SPTB MECOM CEP170 KSR1 TAOK3 HECW2 DSTYK SYNE2 TAOK1 HFM1 DOCK6 NOTCH1 KNL1 NRF1 HECTD4 ZNF407 GRSF1 TBL2 | 1.12e-03 | 1347 | 204 | 20 | EFO_0005192 |
| Disease | Galloway Mowat syndrome | 1.30e-03 | 8 | 204 | 2 | C0795949 | |
| Disease | Hereditary spherocytosis | 1.30e-03 | 8 | 204 | 2 | C0037889 | |
| Disease | Retinal Dystrophies | 1.30e-03 | 8 | 204 | 2 | C0854723 | |
| Disease | Unilateral agenesis of kidney | 1.30e-03 | 8 | 204 | 2 | C0266294 | |
| Disease | urate measurement, bone density | ACTR5 MCC DDX10 RHOBTB2 SEC16A FRAS1 SYNE1 GRID1 DGKD USO1 PLXNC1 DNAH11 | 1.33e-03 | 619 | 204 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Prostate cancer, familial | 1.35e-03 | 69 | 204 | 4 | C2931456 | |
| Disease | obesity | 1.50e-03 | 241 | 204 | 7 | EFO_0001073 | |
| Disease | eosinophil count | BNC2 TRAF3 ATR SPEF2 SPTBN1 LAPTM5 BPTF SEC16A HFM1 NOTCH1 IL19 DHX16 SCHIP1 TCHP TRMT112 WNT11 HECTD4 RAD50 VANGL2 PLXNC1 HDLBP | 1.58e-03 | 1488 | 204 | 21 | EFO_0004842 |
| Disease | Malignant tumor of prostate | 1.66e-03 | 9 | 204 | 2 | cv:C0376358 | |
| Disease | pack-years measurement, systolic blood pressure | 1.66e-03 | 34 | 204 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | breast cancer (is_marker_for) | 1.87e-03 | 185 | 204 | 6 | DOID:1612 (is_marker_for) | |
| Disease | mean platelet volume | SPTA1 SPTBN1 EML6 MECOM ACTN1 PRPS1L1 DSTYK SYNE2 TAOK1 DSE STRN3 NRF1 FRY GCC2 MCM9 MYBPC3 | 2.04e-03 | 1020 | 204 | 16 | EFO_0004584 |
| Disease | Glioblastoma | 2.22e-03 | 79 | 204 | 4 | C0017636 | |
| Disease | IGF-1 measurement | TNFSF10 SPTBN2 NPFFR1 SYNE2 HFM1 DOCK6 NUP98 SLC8A1 HDLBP MYBPC3 | 2.23e-03 | 488 | 204 | 10 | EFO_0004627 |
| Disease | waist-hip ratio | TRAF3 ZNF423 MCC MECOM STAB1 BPTF NRXN3 DSTYK SYNE2 NAV3 TAOK1 PIPSL DOCK6 KNL1 HECTD4 RASSF10 ZNF407 VANGL2 | 2.24e-03 | 1226 | 204 | 18 | EFO_0004343 |
| Disease | FEV/FEC ratio | BNC2 SPEF2 MCC MECOM ITGA1 PTPN4 SYNE2 FRAS1 FAM184A NRBF2 RASSF10 DGKD FTMT SLC1A2 SHISA9 SLC8A1 ZFHX3 HDLBP | 2.28e-03 | 1228 | 204 | 18 | EFO_0004713 |
| Disease | Global developmental delay | 2.36e-03 | 133 | 204 | 5 | C0557874 | |
| Disease | ovarian neoplasm | 2.44e-03 | 134 | 204 | 5 | C0919267 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.51e-03 | 264 | 204 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | Congenital Abnormality | 2.51e-03 | 11 | 204 | 2 | C0000768 | |
| Disease | reticulocyte count | BNC2 ATR SPTA1 SPTB C2orf15 EML6 ACTN1 ITGA1 KAT2B FAT1 DSTYK SYNE2 CCHCR1 NRBF2 HECTD4 TBK1 | 2.60e-03 | 1045 | 204 | 16 | EFO_0007986 |
| Disease | mean arterial pressure | DCDC1 ZNF423 EML6 MECOM CEP170 TAOK3 PREX1 HECTD4 RASSF10 ZFHX3 | 2.61e-03 | 499 | 204 | 10 | EFO_0006340 |
| Disease | smoking behavior | 2.69e-03 | 341 | 204 | 8 | EFO_0004318 | |
| Disease | Malignant neoplasm of ovary | 2.69e-03 | 137 | 204 | 5 | C1140680 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.76e-03 | 200 | 204 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Giant Cell Glioblastoma | 2.78e-03 | 84 | 204 | 4 | C0334588 | |
| Disease | reticulocyte measurement | BNC2 ATR SPTA1 SPTB C2orf15 EML6 ITGA1 KAT2B FAT1 SYNE2 GNAT1 PREX1 NRBF2 HECTD4 TBK1 MYH15 | 2.80e-03 | 1053 | 204 | 16 | EFO_0010700 |
| Disease | Profound Mental Retardation | 2.86e-03 | 139 | 204 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.86e-03 | 139 | 204 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.86e-03 | 139 | 204 | 5 | C0917816 | |
| Disease | depressive symptom measurement | 2.99e-03 | 426 | 204 | 9 | EFO_0007006 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.00e-03 | 12 | 204 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 3.00e-03 | 12 | 204 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | brain disease (is_implicated_in) | 3.00e-03 | 12 | 204 | 2 | DOID:936 (is_implicated_in) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.00e-03 | 12 | 204 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease | 3.07e-03 | 42 | 204 | 3 | cv:C0007959 | |
| Disease | systolic blood pressure, cigarettes per day measurement | 3.53e-03 | 13 | 204 | 2 | EFO_0006335, EFO_0006525 | |
| Disease | obesity (biomarker_via_orthology) | 3.64e-03 | 147 | 204 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Disorder of eye | 3.67e-03 | 212 | 204 | 6 | C0015397 | |
| Disease | Colorectal Carcinoma | TNFSF10 SPTBN2 MCC FAT1 SYNE1 RBP3 GRID1 ARHGEF10L MSH6 DIP2C SPAG17 PRPS1 | 3.72e-03 | 702 | 204 | 12 | C0009402 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | BNC2 TRAF3 DCDC1 ZNF423 BPTF NRXN3 MAD1L1 ASCC3 GOLGA3 ZNF407 MSH6 ZFHX3 NPAS4 | 3.98e-03 | 801 | 204 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | creatinine measurement | CLUAP1 DCDC1 MECOM KAT2B SGSM3 TP53RK ASCC3 NRF1 ZNF607 FRY SLC8A1 PLXNC1 DIP2C TNK2 ZFHX3 | 4.05e-03 | 995 | 204 | 15 | EFO_0004518 |
| Disease | non-high density lipoprotein cholesterol measurement | BNC2 SPTA1 ITGA1 BPTF DSTYK SYNE2 HFM1 ASCC3 ADNP2 USO1 GCC2 DNAH11 | 4.21e-03 | 713 | 204 | 12 | EFO_0005689 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.59e-03 | 222 | 204 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | Autosomal recessive primary microcephaly | 4.71e-03 | 15 | 204 | 2 | cv:C3711387 | |
| Disease | cardiovascular disease | 4.73e-03 | 457 | 204 | 9 | EFO_0000319 | |
| Disease | Schizoaffective disorder-bipolar type | 5.35e-03 | 16 | 204 | 2 | EFO_0009965 | |
| Disease | C-X-C motif chemokine 6 measurement | 5.35e-03 | 16 | 204 | 2 | EFO_0008059 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 5.35e-03 | 16 | 204 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.35e-03 | 16 | 204 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | preeclampsia, parental genotype effect measurement | 5.35e-03 | 16 | 204 | 2 | EFO_0000668, EFO_0005939 | |
| Disease | response to methotrexate | 5.35e-03 | 16 | 204 | 2 | GO_0031427 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 5.35e-03 | 16 | 204 | 2 | C0334634 | |
| Disease | monoclonal gammopathy | 5.92e-03 | 53 | 204 | 3 | EFO_0000203 | |
| Disease | Benign neoplasm of stomach | 6.04e-03 | 17 | 204 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 6.04e-03 | 17 | 204 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 6.04e-03 | 17 | 204 | 2 | C0154060 | |
| Disease | sphingomyelin 14:0 measurement | 6.04e-03 | 17 | 204 | 2 | EFO_0010390 | |
| Disease | susceptibility to common cold measurement | 6.23e-03 | 54 | 204 | 3 | EFO_0008417 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEMVRHALDAHQQSI | 71 | Q16864 | |
| HSISHDDLTRIAKDM | 81 | Q9ULK5 | |
| HLDVVDNLTLMVEHT | 316 | Q6UWZ7 | |
| HLASENSHRISAIMV | 201 | Q7L211 | |
| QVSAIHMDSKVDDHL | 11 | Q8WU43 | |
| AANHTRHDQEERIME | 591 | Q5SW79 | |
| MVDLDQTLIHTTEQH | 186 | Q9Y5B0 | |
| FEAHQDEAVSVTHMV | 1006 | Q9HCE6 | |
| ISIEMHGTLEDQLSH | 656 | P12814 | |
| QVEMGEELVLSIQHH | 821 | Q6P2P2 | |
| VNATMIDHSGVELHL | 3306 | Q7Z408 | |
| TTVNLEDLVVAHHEM | 976 | P12821 | |
| DEHIHSEVSEKVLMN | 741 | Q6ZN30 | |
| AEEHHQLFDLIESML | 446 | P49760 | |
| MELHILEHRLQVASV | 1 | A6NHX0 | |
| ETDTIQHMRDSKHIV | 321 | P50416 | |
| LTERIHQMEENQHST | 396 | Q69YQ0 | |
| ALKERSHHMERIIES | 536 | Q69YQ0 | |
| IHNEVHALGMVDSRE | 2951 | Q96DT5 | |
| AELSDLVSRAMHHLQ | 426 | A6QL63 | |
| SIVMQDTKDEHRLHS | 376 | Q5T2E6 | |
| AITLSRMEEILHEHS | 236 | Q9H9F9 | |
| IQSLLHEMVHAEHVE | 151 | Q12797 | |
| QHRTVAELNHMAEVL | 2171 | Q96M86 | |
| DDIHHVRKSMEVNFL | 131 | P28845 | |
| VVMVDEAHERTLHTD | 516 | O60231 | |
| DTHHVEMARERSKTV | 36 | O14874 | |
| EIHRHMDITEDLTNK | 526 | Q12830 | |
| DDMHRVIDRQLMDTH | 521 | Q6ZP65 | |
| EAKVLHMIHEEQSAQ | 136 | Q6NXP0 | |
| HMAIEAVHSNAIRDK | 491 | Q8NB25 | |
| REVNAMHSLDHRNLI | 176 | Q07912 | |
| IHNSELLLVSGEVMH | 956 | Q6IQ32 | |
| ELNIHLTMNDFSVHR | 181 | P25098 | |
| DVFAENMKLREDTHH | 421 | Q01581 | |
| VSHDRDNMETLVHLI | 176 | O75901 | |
| DNMETLVHLIISQDH | 181 | O75901 | |
| THESASVERMETLVH | 216 | A6NK89 | |
| MHDDSLNTTANLIRH | 321 | Q5RL73 | |
| LDQEMEQLNHHTTTR | 521 | Q92878 | |
| ENTQLVHRVHELEEM | 371 | Q86YS3 | |
| AKEDHERTHQMVLLR | 836 | P57740 | |
| SVHQDDHSLRESMIQ | 631 | P29074 | |
| EDAVAAMLKDRSHVH | 451 | Q12849 | |
| QSLEKHMLSHTEERE | 276 | Q03112 | |
| SVHHRNNRQTMEDLI | 291 | Q14680 | |
| RLNAMLHIDSDEEDH | 456 | Q9P2P5 | |
| SAVTLTVTREEHHFM | 176 | Q9GZQ6 | |
| DHEAVHQHTLTVMVR | 1521 | Q14517 | |
| VLDLMESDLHQIIHS | 136 | Q13164 | |
| LIRHTEAHLSEIQEM | 1626 | M0R2J8 | |
| AVRAHMESDKHLEAL | 1621 | P52948 | |
| EAARHEHQVMLMRQD | 301 | Q15233 | |
| AQERMHHDIVRLLDE | 2101 | P46531 | |
| HLKVTDIDSDDHQVM | 2101 | Q86XX4 | |
| EDEEVNRMHESLHLF | 236 | A8MTJ3 | |
| AMHFAEKHLEISREV | 341 | P81274 | |
| REAEDMVQKVHSHSA | 436 | Q9Y6D9 | |
| EHMVITDRIENIDHL | 201 | Q9Y287 | |
| HVSHLENVSEEEMNR | 146 | Q92831 | |
| VEDDEVNRMHESLHL | 231 | P11488 | |
| RRCLISTDMHHIEES | 26 | Q9UHD0 | |
| IDVNALEMVAHISEH | 4471 | Q2LD37 | |
| RTLEDIFHEHMQELI | 256 | Q5XUX0 | |
| HSLPEVQQHMREESR | 4396 | Q9Y6V0 | |
| DVIQVSHVLNDTHMK | 706 | O60486 | |
| VAIRLLEMDGHNQDH | 636 | Q8IVT5 | |
| AHREAVEHFLEALNM | 571 | P50542 | |
| ALSSAHHLDQIREAM | 1821 | Q8IVL0 | |
| MVGDHTRLEFHNIET | 801 | Q9Y4C0 | |
| VTQTEHMATIEAHAV | 6 | Q16656 | |
| ERDHVAMLASVTHSD | 306 | Q96LW2 | |
| HIAARLTEAVHTMLS | 66 | Q9UL01 | |
| FVDNHVELEMTESHT | 971 | Q8NG31 | |
| MSEFRIHHDVNELLS | 1 | Q9BSJ2 | |
| EERISAHHVPNMVAT | 541 | P03971 | |
| EELRHLAHANISMDI | 521 | Q96KJ4 | |
| TVHEREVQTAMQISH | 101 | Q96E09 | |
| HNLIDTITGMHSVEV | 396 | Q96FC9 | |
| HVANSMAAEVIALLH | 1656 | Q9Y4D8 | |
| MVIVTDGESHDNHRL | 276 | P56199 | |
| LMHATAHSLVLVDEL | 1201 | P52701 | |
| HLQSAQKERDEMETH | 921 | Q08378 | |
| SLQRQMEEHALTVHE | 1441 | Q08378 | |
| TLTAIAVDRHQVIMH | 161 | Q9NYM4 | |
| ESRDEHLHEMALEQI | 2261 | A2RRP1 | |
| HLHEMALEQITAVTT | 2266 | A2RRP1 | |
| AELEVTMHHALLQEV | 206 | Q6XUX3 | |
| TMHHALLQEVDVVVA | 211 | Q6XUX3 | |
| EQAHLSLELQRDSHM | 51 | Q96F24 | |
| SLLMSIHNIDHAQRE | 271 | A2A3N6 | |
| LVAHEVARMRADENH | 446 | O95248 | |
| DDLFEIQHAHIIMTT | 371 | A2PYH4 | |
| VSEHLGHSMVDLVAQ | 101 | Q8IUM7 | |
| EIMAVLKHDDQHTIN | 1551 | Q13535 | |
| SHLMREHEDVQERTT | 61 | P23508 | |
| HVALLTHVDSMDLIT | 341 | Q8TCB0 | |
| HQLEADHSRMKREVS | 171 | Q9BXL6 | |
| DVKHDVMSNQSVLHR | 1066 | Q8NCX0 | |
| EAMAHVVSLVHRSLE | 806 | Q96HP0 | |
| LLGDTLEEVHIHSTM | 6 | P57773 | |
| LDDRSQEHLHFVMEI | 831 | O75912 | |
| ALIAEMIHTASLVHD | 166 | Q5T2R2 | |
| MIHTASLVHDDVIDD | 171 | Q5T2R2 | |
| SQHRVHEDIEMTKTQ | 506 | P43004 | |
| LETNHTELMEHEASL | 316 | Q9BV73 | |
| EAHNLIDTITGMHSV | 396 | A8MPP1 | |
| HDTLLERHNKMLQET | 1386 | Q8IWJ2 | |
| DVEVHLEDQMVLVHT | 41 | O14618 | |
| RLADVMAQTHIENHS | 191 | Q9Y2E4 | |
| TMQHLQEDRDSLHAT | 276 | Q8TD31 | |
| EELSHTLKHTQIRMD | 416 | Q494V2 | |
| ELATAKSDMNRHLHE | 441 | Q5TF58 | |
| AELAVFHRDVHMLLV | 176 | Q9NTJ4 | |
| LIHSIREIAQSHRDM | 991 | Q16760 | |
| SHRDMEQELAHAVNA | 1001 | Q16760 | |
| ALEHAFQLEHIMDLT | 2436 | Q14204 | |
| QDLLDLMHTLHTRAA | 1496 | Q92538 | |
| VHRRMNSLMDEDIAH | 876 | Q9ULK0 | |
| VVNADTVEDMVSFHH | 1066 | Q6ZMW3 | |
| LLQHMDETVSFHATD | 201 | Q13206 | |
| RLSIHMDDELRHIAQ | 631 | Q5TBA9 | |
| LREVNDMHHTLLDSS | 671 | Q5TBA9 | |
| LLAMERHGVDHQVIS | 386 | Q15020 | |
| IHPQELRQISHTEME | 521 | Q16531 | |
| LHQSREETEHAEKLM | 116 | Q8N4E7 | |
| IIMLDEAHERTIHTD | 681 | Q14562 | |
| EASSHIQDDMHLVIR | 546 | Q9BXW9 | |
| KRHLEEHVDVLMTSN | 281 | O00487 | |
| EHDRTSIHEAMEQQT | 421 | Q9NXL9 | |
| AMEHLIHVLQTDRSD | 61 | O60763 | |
| SLAVSHMVAAEIHQR | 1261 | Q9C093 | |
| IHSMVAHLDAVTSLA | 716 | Q13033 | |
| TTRLEAVREMSETHH | 146 | Q96JX3 | |
| HVTEILADIQSHMDR | 291 | Q96DX7 | |
| LDIHQAMASEHSTLA | 701 | Q96KN7 | |
| VESFDDQRRMSLHLH | 1946 | O60522 | |
| ETAMETLINVFHAHS | 6 | P23297 | |
| HDHMEQLKELTSTVR | 3791 | Q8NF91 | |
| KEQLSHRQHLLSEME | 5666 | Q8NF91 | |
| GLIMHEEENLDRLHQ | 5511 | Q8WXH0 | |
| MSVLLFIEHSVEVAH | 31 | Q13571 | |
| IEDLTRHAESQQKHM | 466 | P0DPB3 | |
| RIVQLSHVMDSHVSE | 906 | A1L390 | |
| LHRDMEEATLHFETT | 1186 | Q9Y2K3 | |
| LVMDCHRTHLSEEVL | 1226 | Q7Z3K3 | |
| HRTHLSEEVLAMLSA | 1231 | Q7Z3K3 | |
| ESTHEDRNVEHMAEV | 216 | O60921 | |
| EDDEVNRMHESLHLF | 236 | P19087 | |
| QRHIKAMHESALLEE | 961 | O75376 | |
| RSIRDAEDMVTHHTL | 606 | P48764 | |
| LHLSHRVEQSTDDMI | 1771 | Q96Q15 | |
| EESQMHLLNSEHLAT | 411 | Q96QT6 | |
| NERDLMHIAHIAELL | 441 | Q9BYZ6 | |
| MVTLTVDNVHLEHGV | 841 | Q8TCU6 | |
| VTHDAVHAQMDVKLR | 641 | Q96HU1 | |
| NTDHMERDLNIVVHV | 201 | B4DS77 | |
| DLEHAMLLRQHESMQ | 646 | Q7L7X3 | |
| HESMQELEFRHLNTI | 656 | Q7L7X3 | |
| HAMLIRHDESTRELE | 646 | Q9H2K8 | |
| RVGLTHTMEHEDVIQ | 346 | P55039 | |
| ADHIITMDLHASQIQ | 121 | P21108 | |
| AHISHNIEIMTEHEV | 2156 | Q6Q759 | |
| ERVHRLEMAIAFHSN | 596 | Q86VW0 | |
| QRVHLENMGSHDIVD | 126 | Q01082 | |
| TLQRMHTTFEHDIQA | 1841 | Q01082 | |
| TDLPVRHNEDHMNSE | 1856 | Q8N3C0 | |
| RSHHTDLADLQMVTD | 181 | Q6ZU45 | |
| HHRMEQERFEEAKNT | 276 | Q96AJ1 | |
| HIREEVSQLRHELSM | 156 | Q9UPV9 | |
| LEVSTHMNDERHKET | 971 | Q70EK8 | |
| MLRVHLDIQVGEHAN | 136 | Q9BVK6 | |
| IEDHSIRELVTQMIH | 281 | Q99570 | |
| SERLTMHLVEEHSVV | 276 | Q9Y4G8 | |
| LLHSHDTETRATMNL | 61 | Q9HCU5 | |
| ASDLKRHENNMHSER | 401 | O43829 | |
| EVNANPSMRIEHEHE | 531 | Q8NHH1 | |
| LESQLSRHDQMLSVH | 381 | Q13114 | |
| SRHDQMLSVHDIRLA | 386 | Q13114 | |
| EEHLHSTTVTAAMRI | 1676 | Q8IZQ1 | |
| HVLEDMNEFTVHILE | 146 | Q13156 | |
| DRRTNITQEHFSHME | 511 | P10745 | |
| VEVHSMEALLQHTSE | 1476 | O15027 | |
| SQDMIDHEHPESTRI | 1651 | O15020 | |
| LHSTVTHNIREERME | 151 | Q9NXZ1 | |
| ENEEFLRTMHHLLLE | 76 | Q9UI30 | |
| DLVHRQTASAVVQHM | 1181 | O75533 | |
| MDESKHEIHSQVDAI | 536 | Q9Y490 | |
| FSELDQHPMDRVLTH | 596 | Q14515 | |
| ADHIITMDLHASQIQ | 121 | P11908 | |
| DIHRSLMVDHVTEVS | 166 | Q9HD15 | |
| LTELMVHQTIHTSEE | 126 | Q96SK3 | |
| VITGVDSVMNHHLQE | 71 | Q56UQ5 | |
| LIIATTHADIMHLTD | 1111 | Q5SRE5 | |
| THADIMHLTDSVVRR | 1116 | Q5SRE5 | |
| TVRHHVVLGEALSME | 1186 | Q9NY15 | |
| LMHVDEFIDELLHSE | 141 | Q8NAV1 | |
| REMELDLHQKHVVNS | 151 | Q9BT92 | |
| NIDHETHELTRMNLQ | 131 | O15492 | |
| QRVHLENMGSHDIVD | 126 | P11277 | |
| ILLERHQEHRADMEA | 1326 | P02549 | |
| HVDFEAMLRQHRLSE | 166 | Q9BW85 | |
| HTLLDALERMEERHA | 426 | O00220 | |
| SNLELMHTVVHAARE | 61 | O96014 | |
| LAVHMEEHRQELAGT | 136 | Q9UL36 | |
| EVLSHQEQHMLAVSE | 71 | Q8TF50 | |
| IGQVLARMHDEDLIH | 146 | Q96S44 | |
| ADHIITMDLHASQIQ | 121 | P60891 | |
| ESHMQVDHRDLTPET | 1136 | Q2M1K9 | |
| QMVSEDVPLDHRVHA | 1126 | Q00341 | |
| SHDELMVHEETVKND | 76 | Q9UQR1 | |
| SMSRRDLDEHLHSNQ | 566 | Q9C0G0 | |
| IFVSVTNEHLIDMDH | 256 | P50591 | |
| LITHVRTHMDENLFV | 501 | Q9UEG4 | |
| IMATDGTQLHHIELT | 926 | Q9H4Z2 | |
| IRDVINVHMEELSNH | 241 | Q6IEG0 | |
| EHRSMRANVELDHAT | 126 | Q9Y4P3 | |
| DTLVELTVHMNETGH | 256 | Q6ZSZ6 | |
| ETSDILHRMVIHVFS | 301 | Q9UHD2 | |
| QNSELIMHEKTHTRE | 341 | P51508 | |
| ALSLMRSHNDEHSDV | 1921 | O95071 | |
| HMVHDSVVEAEIITD | 151 | P08048 | |
| AVHDHRMTLSEDERK | 301 | Q15911 | |
| ENLLMRIHFHIADET | 126 | Q70EL1 | |
| LFSHVDHVIAETEME | 26 | P32418 | |
| MQLQHLVEGEHVTSD | 1041 | Q9NQX4 | |
| DHTLIENGEMIRILH | 106 | Q9H1M0 | |
| DGQRHHLIINEAMLE | 506 | Q14896 |